Immunologic Aspects of Renal Disease

  • William G. Couser


In this chapter, I shall present an overview of the advances made in understanding immune disease mechanisms during 1984–1985, with particular attention to new directions, ideas, and processes that have significant promise for the future. In taking this approach, I shall inevitably exclude isolated observations of significant merit that do not blend easily into the currents of the field in general. For similar reasons, included here will be studies of less significance that are reviewed because they provide links, or potential links, between larger areas of relatively greater importance.


Nephrotic Syndrome Lupus Nephritis Membranous Nephropathy Minimal Change Nephrotic Syndrome Immune Deposit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Couser, W. G., 1985, Mechanisms of glomerular injury in immune-complex disease, Nephrol Forum 28: 569–583.Google Scholar
  2. 2.
    Salant, D.J., Adler, S., Darby, C., Capparell, N.J., Groggel, G. C., Feintzeig, I. D., Rennke, H. G., and Dittmer, J. E., 1985, Influence of antigen distribution on the mediation of immunological glomerular injury, Kidney Int. 27: 938–950.PubMedGoogle Scholar
  3. 3.
    Kerjaschki, D. and Farquhar, M. G., 1982, The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border, Proc. Natl Acad. Sci. USA 79: 5557–5561.PubMedGoogle Scholar
  4. 4.
    Kerjaschki, D. and Farquhar, M. G., 1983, Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats, J. Exp. Med. 157: 667–686.PubMedGoogle Scholar
  5. 5.
    Kerjaschki, D., Noronha-Blob, L., Sacktor, B., and Farquhar, M. G., 1984, Microdomains of distinctive glycoprotein composition in the kidney proximal tubule brush border, J. Cell Biol 98: 1505–1513.PubMedGoogle Scholar
  6. 6.
    Bhan, A. K., Schneeberger, E. E., Baird, L. G., Collins, A. B., Kamata, K., Bradford, D., Erikson, M. E., and CmCluskey, R. T., 1985, Studies with monoclonal antibodies against brush border antigens in Heymann nephritis, Lab. Invest. 53: 421–432.PubMedGoogle Scholar
  7. 7.
    Makker, S. P. and Singh, A. K., 1984, Characterization of the antigen (gp600) of Heymann nephritis, Lab. Invest. 50: 287–293.PubMedGoogle Scholar
  8. 8.
    Abrass, C. K., 1984, Direct binding of renal tubular antigen to the subepithelal space of the glomerulus, Abstr. 9th Int. Cong. Nephrol., Los Angeles, p. 231a (Abstr.).Google Scholar
  9. 9.
    Kamata, K., Baird, L. G., Erikson, M. E., Collins, A. B., and McCluskey, R. T., 1985, Characterization of antigens and antibody specificities involved in Heymann nephritis, J. Immunol 135: 2400–2408.PubMedGoogle Scholar
  10. 10.
    Neale, T. J., Woodroffe, A. J., and Wilson, C. B., 1984, Spontaneous glomerulonephritis in rabbits. Role of a glomerular capillary antigen, Kidney Int. 26: 701–711.PubMedGoogle Scholar
  11. 11.
    Barabas, A. Z., Cornish, J., and Lannigan, R., 1985, Passive Heymann-like nephritis in the rabbit, Br. J. Ext. Pathol 66: 357–364.Google Scholar
  12. 12.
    Assmann, K. J. M., Ronco, P., Tangelder, M. M., Lange, W. P. H., Verroust, P., and Koene, R. A. P., 1985, Comparison of antigenic targets involved in antibody-mediated membranous glomerulonephritis in the mouse and rat, Am. J. Pathol 121: 112–122.PubMedGoogle Scholar
  13. 13.
    Barba, L. M., Caldwell, P. R. B., Downie, G. H., Camussi, G., Brentjens, J. R., and Andres, G., 1983, Lung injury mediated by antibodies to endothelium, J. Exp. Med. 158: 2140–2158.Google Scholar
  14. 14.
    Matsuo, S., Caldwell, P. R. B., Brentjens, J. R., and Andres, G., 1985, In vivo interaction of antibodies with cell surface antigens: A mechanism responsible for in situ formation of immune deposits in the zona pellucida of rabbit oocytes, J. Clin. Invest. 75: 1369–1380.Google Scholar
  15. 15.
    Camussi, G., Brentjens, J. R., Noble, B., Kerjaschki, D., Malavasi, F., Roholt, O. A., Farquhar, M. G., and Andres, G., 1985, Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells; Possible role in the pathogenesis of Heymann glomerulonephritis, J. Immunol. 135: 1–8.Google Scholar
  16. 16.
    Abrass, C. K., 1984, Autologous immune complex nephritis in rats: Influence of modification of mononuclear phagocyte system function, Lab. Invest. 51: 162–171.PubMedGoogle Scholar
  17. 17.
    Zamlauski-Tucker, M. J., Van Liew, J. B., and Noble, B., 1985, Pathophysiology of the kidney in rats with Heymann nephritis, Kidney Int. 28: 504–512.PubMedGoogle Scholar
  18. 18.
    Park, E. K., Hong, S. K., and Goldinger, J., 1985, Impaired organic ion transport in proximal tubules of rats with Heymann nephritis, Proc. Soc. Exp. Biol. Med. 180: 174–184.PubMedGoogle Scholar
  19. 19.
    Adler, S., Striker, L., Striker, G., Perkinson, D., Hibbert, J., and Couser, W., 1985, Mechanisms of progressive glomerular sclerosis in the rat, Kidney Int. 27:204 (Abstr.).Google Scholar
  20. 20.
    Ward, H. J., Cohen, A. H., and Border, W. A., 1984, In situ formation of subepithelial immune complexes in the rabbit glomerulus: Requirement of a cationic antigen, Nephron 36: 257–264.Google Scholar
  21. 21.
    Adler, S., Baker, P., Pritzl, P., and Couser, W. G., 1985, Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat, J. Lab. Clin. Med. 106: 1–11.PubMedGoogle Scholar
  22. 22.
    Vogt, A., Batsford, S., Rodriguez-Iturbe, B., and Garcia, R., 1983, Cationic antigens in poststreptococcal glomerulonephritis, Clin. Nephrol. 20: 271–279.PubMedGoogle Scholar
  23. 23.
    Vogt, A., 1984, New aspects of the pathogenesis of immune complex glomerulonephritis: Formation of subepithelial deposits, Clin. Nephrol. 21: 15–20.PubMedGoogle Scholar
  24. 24.
    Madaio, M. P., Salant, D. J., Adler, S., Darby, C., and Couser, W. G., 1984, Effect of antibody charge and concentration on glomerular deposition of anti-GBM antibody, Kidney Int. 26: 397–403.PubMedGoogle Scholar
  25. 25.
    Ebling, F. and Hahn, B., 1980, Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus, Arthritis Rheum. 23: 392–403.PubMedGoogle Scholar
  26. 26.
    Gay, S., Losman, M. L., Koopman, W. J., and Miller, E. J., 1985, Interaction of DNA with connective tissue matrix proteins reveals preferential binding to type V collagen, J. Immunol. 135: 1097–1100.Google Scholar
  27. 27.
    Agodoa, L. Y. C., Gauthier, V. J., and Mannik, M., 1985, Antibody localization in the glomerular basement membrane may precede in situ immune deposit formation in rat glomeruli, J. Immunol. 134: 880–884.PubMedGoogle Scholar
  28. 28.
    Fleuren, G., Ground, J., and Hoedemaeker, P. J., 1980, In situ formation of subepithelial glomerular immune complexes in passive serum sickness, Kidney Int. 17: 631–637.Google Scholar
  29. 29.
    Barnes, J. L., Camussi, G., Tetta, C., and Venkatachalam, M. A., 1985, Glomerular localization of platelet cationic proteins following immune complex induced platelet activation, Kidney Int. 27:206 (Abstr.).Google Scholar
  30. 30.
    Barnes, J. L., Levine, P. S., and Venkatachalam, M. A., 1984, Binding of platelet factor four (PF4) to glomerular polyanion, Kidney Int. 25: 759–765.PubMedGoogle Scholar
  31. 31.
    Barnes, J. L. and Venkatachalam, M. A., 1984, Enhancement of glomerular immune complex deposition by circulating polycation, J. Exp. Med. 160: 286–293.PubMedGoogle Scholar
  32. 32.
    Cavallo, T., Goldman, M., Graves, K., and Lambert, P-H., 1983, Altered glomerular permeability in the early phase of immune complex nephritis, Kidney Int. 24: 632–637.PubMedGoogle Scholar
  33. 33.
    Caulin-Glaser, T., Gallo, G., and Lamm, M. E., 1983, Nondissociating cationic immune complexes can deposit in glomerular basement membrane, J. Exp. Med. 158: 1561–1572.PubMedGoogle Scholar
  34. 34.
    Gallo, G. R. and Lamm, M. E., 1985, Glomerular deposition diseases: Insights into mechanisms, Uremia Invest. 8: 189–192.Google Scholar
  35. 35.
    Caulin-Gaser, T., Kanwar, Y. S., Gallo, G. R., and Lamm, M. E., 1985, Interaction of immune-complexes with heparan sulfate enriched anionic sites of glomerular extracellular matrices, Kidney Int. 27:21Q.Google Scholar
  36. 36.
    Caulin-Glaser, T., Kanwar, Y. S., Gallo, G. R., and Lamm, M. E., 1985, Charge-related deposition of immune complexes in glomerular basement membrane is independent of Fc effector function, Am. J. Pathol. 119–288.Google Scholar
  37. 37.
    Matsuo, S., Caldwell, P., Brentjens, J., and Andres, G., 1985, Nephrotoxic serum glomerulonephritis induced in the rabbit by anti-endothelial antibodies, Kidney Int. 27:217 (Abstr.).Google Scholar
  38. 38.
    Yamamoto, T. and Wilson, C. B., 1986, Antibody-induced mesangial cell damage: The model, functional alterations, and effects of complement, Kidney Int. 29:296 (Abstr.).Google Scholar
  39. 39.
    Cines, D. B., Lyss, A. P., Reebert, M. B., and DeHoratius, R. J., 1984, Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus, J. Clin. Invest. 73: 611–625.Google Scholar
  40. 40.
    Waxman, F. J., Hebert, L. A., Cornacoff,J. B., VanAman, M. E., Smead, W. L., Kraut, E. H., Birmingham, D. J., and Taguiam, J. M., 1984, Complement depletion accelerates the clearance of immune complexes from the circulation of primates, J. Clin. Invest. 74: 1329–1340.Google Scholar
  41. 41.
    Gauthier, V. J., Striker, G. E., and Mannik, M., 1984, Glomerular localization of immune complexes prepared with anionic antibodies or with cationic antigen, Lab. Invest. 50: 125–137.Google Scholar
  42. 42.
    Valentijin, R. M., van Es, L. A., and Daha, M. R., 1984, The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes, J. Clin. Lab. Immunol. 14: 81–86.Google Scholar
  43. 43.
    Kilpatrick, D. C. and Weston, J., 1985, Immune complexes assays and their limitations, Med. Lab. Sci. 42: 178–185.PubMedGoogle Scholar
  44. 44.
    Horgan, C. and Taylor, R. P., 1984, Quantitative analyses of complement fixation in three immune complex systems, Immunology 52: 753–759.PubMedGoogle Scholar
  45. 45.
    Doekes, G., Van Es, L. A., and Daha, M. R., 1984, Binding and activation of the first complement component by soluble immune complexes: Effect of complex size and composition, Scand. J. Immunol. 19: 99–110.PubMedGoogle Scholar
  46. 46.
    Jacob, L., Tron, F., Bach, J-F., and Louvard, D., 1984, A monoclonal antiDNA antibody also binds to cell-surface protein(s), Proc. Natl. Acad. Sci. USA 81: 3843–3845.PubMedGoogle Scholar
  47. 47.
    Uwatoko, S., Aotsuka, S., Okawa, M., Egusa, Y., Yokohari, R., Aizawa, C., and Suzuki, K., 1984, Characterization of Clq-binding IgG complexes in systemic lupus erythematosus, Clin. Immunol. Immunopathol. 30: 104–116.PubMedGoogle Scholar
  48. 48.
    Wieslander, J., Bygren, P., and Heinegard, D., 1983, Andglomerular basement membrane antibody: Antibody specificity in different forms of glomerulonephritis, Kidney Int. 23: 855–861.PubMedGoogle Scholar
  49. 49.
    Wieslander, J., Bygren, P., and Heinegard, D., 1984, Isolation of the specific glomerular basement membrane antigen involved in Goodpasture syndrome, Proc. Natl. Acad. Sci. USA 81: 1544–1548.PubMedGoogle Scholar
  50. 50.
    Yoshioka, K., Kleppel, M., and Fish, A. J., 1985, Analysis of nephritogenic antigens in human glomerular basement membrane by two-dimensional gel electrophoresis, J. Immunol. 134: 3831–3837.PubMedGoogle Scholar
  51. 51.
    Fish, A. J., Lockwood, M. C., Wong, M., and Price, R. G., 1984, Detection of Goodpasture antigen in fractions prepared from collagenase digests of human glomerular basement membrane, Clin. Exp. Immunol. 55: 58–66.PubMedGoogle Scholar
  52. 52.
    Yoshioka, K., Michael, A. F., Velosa, J., and Fish, A. J., 1985, Detection of hidden nephritogenic antigen determinants in human renal and nonrenal basement membranes, Am. J. Pathol. 121: 156–165.PubMedGoogle Scholar
  53. 53.
    Butkowski, R. J., Wieslander, J., Wisdom, B. J., Barr, J. F., Noelken, M. E., and Hudson, B. G., 1985, Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen, J. Biol. Chem. 260: 3739–3747.PubMedGoogle Scholar
  54. 54.
    Wilson, C. B., and Dixon, F. J., 1986, Renal response to immunologic injury, in: The Kidney, 3rd ed. (B. M., Brenner, and F. C. Rector, Jr., eds), Saunders, Philadelphia, Chapter 20, pp. 800–890.Google Scholar
  55. 55.
    Yoshioka, K., Kleppel, M., Price, R. G., Michael, A. F., and Fish, A. J., 1984, Characterization of Goodpasture (GP) antigen(s) by high-resolution two-dimensional electrophoresis, Kidney Int. 25:221 (Abstr.).Google Scholar
  56. 56.
    Fish, A. J., Toshioka, K., Kleppel, M., Walker, P., and Michael, A. F., 1984, Heterogeneity of the autoimmune response in human antiglomerular basement membrane (antiGBM) nephritis, Fed. Proc. 43: 1589 (Abstr.).Google Scholar
  57. 57.
    Keraj, K., Fish, A. J., Yoshioka, K., and Michael, A. F., 1984, Development of heterogeneity of antigens in the immature nephron, Am. J. Pathol. 117: 180–183.Google Scholar
  58. 58.
    Kerjaschki, D., Sharkey, D. J., and Farquhar, M. G., 1984, Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell, J. Cell Biol. 98: 1591–1596.PubMedGoogle Scholar
  59. 59.
    Huang, T. and Langlois, J., 1985, A new cell surface protein of the podocyte and endothelium, J. Exp. Med. 162: 245–267.PubMedGoogle Scholar
  60. 60.
    Murphy-Ullrich, J. E. and Oberley, T. D., 1984, Immune-mediated injury to basement membranes in mice immunized with murine laminin, Clin. Immunol. Immunopathol. 31: 33–43.PubMedGoogle Scholar
  61. 61.
    Kanwar, Y. S., 1984, Biophysiology of glomerular filtration and protein uria, Lab. Invest. 51: 7–21.PubMedGoogle Scholar
  62. 62.
    Couser, W. G., Baker, P. J., and Adler, S., 1985, Complement and the direct mediation of immune glomerular injury: A new perspective, Kidney Int. 28: 879–890.PubMedGoogle Scholar
  63. 63.
    Couser, W. G., Darby, C., Salant, D. J., Adler, S., Stilmant, M. M., and Lowenstein, L. M., 1985, Anti-GBM antibody-induced proteinuria in isolated perfused rat kidney, Am. J. Physiol. 249: F241–F250.PubMedGoogle Scholar
  64. 64.
    Groggel, G. C., Adler, S., Rennke, H. G., Couser, W. G., and Salant, D. J., 1983, Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit, J. Clin. Invest. 72: 1948–1957.PubMedGoogle Scholar
  65. 65.
    Baker, P. J., Ochi, R., Adler, S., Johnson, R. J., and Couser, W. G., 1985, C6 depletion abolishes proteinuria in experimental membranous nephropathy, Clin. Res. 33–. 475A (Abstr.).Google Scholar
  66. 66.
    Ochi, R. F., Johnson, R. J., Baker, P. J., Adler, S., and Couser, W. G., 1986, C6 depletion diminishes proteinuria in experimental membranous nephropathy induced by an exogenous antigen, Kidney Int. 29:287 (Abstr.).Google Scholar
  67. 67.
    Adler, S., Baker, P. J., Pritzl, P., and Couser, W. G., 1984, Detection of terminal complement components in experimental immune glomerular injury, Kidney Int. 26: 830–837.PubMedGoogle Scholar
  68. 68.
    Perkinson, D. T., Baker, P. J., Couser, W. G., Johnson, R. J., and Adler, S., 1985, Membrane attack complex deposition in experimental glomerular injury, Am. J. Pathol. 120: 121–128.PubMedGoogle Scholar
  69. 69.
    Biesecker, G., Noble, B., Andres, G. A., and Koffler, D., 1984, Immunopathogenesis of Heymann’s nephritis, Clin. Immunopathol. 33: 333–338.Google Scholar
  70. 70.
    De Heer, E., Daha, M. R., Bhakdi, S., Bazin, H., and van Es, L. A., 1985, Possible involvement of terminal complement complex in active Heymann nephritis, Kidney Int. 22: 388–393.Google Scholar
  71. 71.
    Groggel, G. C., Salant, D. J., Darby, C., Rennke, H. G., and Couser, W. G. 1985, Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis, Kidney Int. 27: 643–651.PubMedGoogle Scholar
  72. 72.
    Falk, R. J., Dalmasso, A. P., Kim, Y., Tsai, C. H., Scheinman, J. I., Gewurz, H. and Michael, A. F., 1983, Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease, J. Clin. Invest. 72: 560–573.PubMedGoogle Scholar
  73. 73.
    Parra, G., Piatt, J. L., Falk, R. J., Rodriguez-Iturbe, B., and Michael, A. F., 1984, Cell populations and membrane attack complex in glomeruli of patients with post-streptococcal glomerulonephritis: Identification using monoclonal antibodies by indirect immunofluorescence, Clin. Immunol. Immunopathol. 33: 324–332.PubMedGoogle Scholar
  74. 74.
    Baker, P. J., Adler, S., Yang, Y., and Couser, W. G., 1984, Complement activation by heat-killed human kidney cells: Formation activity and stabilization of cell bound C3 convertases, J. Immunol. 133: 877–881.PubMedGoogle Scholar
  75. 75.
    Koffler, D., Biesecker, G., Noble B., Andres, G. A., and Martinez-Hernandez, A., 1983, Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis, J. Exp. Med. 157: 1885–1905.PubMedGoogle Scholar
  76. 76.
    Hansch, G. M., Seitz, M., Martinotti, G., Betz, M., Rauterberg, E. W., and Gemsa, D., 1984, Macrophages release arachidonic acid, prostaglandin E2 and thromboxane in response to late complement components, J. Immunol. 133: 2145–2150.PubMedGoogle Scholar
  77. 77.
    Lovett, D., Hansch, G., Resch, K., and Gemsa, D., 1984, Activation of glomerular mesangial cells (MC) by terminal complement components: Stimulation of prostanoid and interleukin l(Il-l)-like factor release, Immunobiology 168:34–35 (Abstr.).Google Scholar
  78. 78.
    Adler, S., Baker, P. J., Johnson, R. J., Ochi, R. F., Pritzl, P., and Couser, W. G., 1986, Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells J, Clin, Invest, 77: 762–767.Google Scholar
  79. 79.
    Rehan, A., Johnson, K. J., Kunkel, R. G., and Wiggins, R. C., 1984, Role of oxygen radicals in phorbol myristate acetate-indiced glomerular injury, Kidney Int. 27: 503–511.Google Scholar
  80. 80.
    Rehan, A., Wiggins, R. C., Kunkel, R. G., Till, G. O., and Johnson, K. J., 1986, Glomerular injury and proteinuria in rats after intrarenal injection of cobra venom factor, Am. J. Pathol. 123: 57–66.PubMedGoogle Scholar
  81. 81.
    Rehan, A., Johnson, K. J., Wiggins, R. C., Kunkel, R. G., and Ward, P. A., 1984, Evidence for the role of oxygen radicals in acute nephrotic nephritis, Lab. Invest. 51: 396–403.PubMedGoogle Scholar
  82. 82.
    Johnson, R. J., Klebanoff, S. J., and Couser, W. G., 1986, The myeloperoxidase-hydrogen peroxide-halide system: A new mediator of glomerulonephritis, Kidney Int. 29:278 (Astr.).Google Scholar
  83. 83.
    Holdsworth, S. R. and Neale, T. J., 1984, Macrophage-induced glomerular injury: Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis, Lab. Invest. 51: 172–180.PubMedGoogle Scholar
  84. 84.
    Holdsworth, S. R. and Bellomo, R., 1984, Differential effects of steroids on leukocyte-mediated glomerulonephritis in the rabbit, Kidney Int. 26: 162–169.PubMedGoogle Scholar
  85. 85.
    Tipping, P. G. and Holdsworth, S. R., 1985, The mechanism of action of corticosteroids on glomerular injury in acute serum sickness in rabbits, Clin. Exp. Immunol. 59: 555–563.PubMedGoogle Scholar
  86. 86.
    Baud, L., Sraer, J., Delarue, F., Bens, M., Balavoine, F., Schlondorff, D., Ardaillou, R., and Sraer, J. D., 1985, Lipoxygenase products mediate the attachment of rat macrophages to glomeruli in vitro, Kidney Int. 27: 855–863.Google Scholar
  87. 87.
    Tipping, P. G., Neale, T. J., and Holdsworth, S. R., 1985, T lymphocyte participation in antibody-induced experimental glomerulonephritis, Kidney Int. 27: 530–537.PubMedGoogle Scholar
  88. 88.
    Hooke, D. H., Hancock, W. W., Gee, D. C., Kraft, N., and Atkins, R. C., 1984, Monoclonal antibody analysis of glomerular hypercellularity in human glomerulonephritis, Clin. Nephrol. 22: 163–168.PubMedGoogle Scholar
  89. 89.
    Ferrario, F., Castiglione, A., Colasanti, G., Di Belgioioso, G. B., Bertoli, S., and D’Amico, G., 1985, The detection of monocytes in human glomerulonephritis, Kidney Int. 28: 513–519.PubMedGoogle Scholar
  90. 90.
    Stachura, I., Si, L., and Whiteside, T. L., 1984, Mononuclear-cell subsets in human idiopathic crescentic glomerulonephritis (ICGN): Analysis in tissue sections with monoclonal antibodies, J. Clin. Immunol. 4: 202–208.PubMedGoogle Scholar
  91. 91.
    Schreiner, G. F. and Unanue, E. R., 1984, The origin of the rat mesangial phagocyte and its expression of the leukocyte common antigen, Lab. Invest. 51: 515–523.PubMedGoogle Scholar
  92. 92.
    Schreiner, G. F., Cotran, R. S., and Unanue, E. R., 1984, The modulation of la and LC antigen expression in rat glomeruli during the course of glomerulonephritis and aminonucleoside nephritis, Lab. Invest. 51: 524–533.PubMedGoogle Scholar
  93. 93.
    Hinglais, N., Kazatchkine, M. D., Charron, D. J., Appay, M-D., Mandet, C., Paing, M., and Bariety, J., 1984, Immunohistochemical study of la antigen in the normal and diseased human kidney, Kidney Int. 25: 544–550.PubMedGoogle Scholar
  94. 94.
    Bolton, W. K., Tucker, F. L., and Sturgill, B. C., 1984, New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity nonhumorally mediated glomerulonephritis in chickens, J. Clin. Invest. 73: 1263–1276.PubMedGoogle Scholar
  95. 95.
    Tucker, F. L., Sturgill, B. C., and Bolton, W. K., 1985, Ultrastructural studies of experimental autoimmune glomerulonephritis in normal and bursectomized chickens, Lab. Invest. 53: 563–570.PubMedGoogle Scholar
  96. 96.
    Chandra, M., Tyson, T., Sturgill, B., and Bolton, K., 1985, Transfer of experimental autoimmune glomerulonephritis in chickens by sensitized cells, Kidney Int. 27:208 (Abstr.).Google Scholar
  97. 97.
    Bhan, A. K., Schneeberger, E. E., Collins, A. B., and McCluskey, R. T., 1984, Systemic cell-mediated reactions in vivo, Am. J. Pathol. 16: 77–84.Google Scholar
  98. 98.
    Bolton, W. K., 1984, The role of cell mediated immunity in the pathogenesis of glomerulonephritis, Plasma Ther. Transfus. Technol. 5: 415–430.Google Scholar
  99. 99.
    Lovett, D. H., Sterzel, R. B., Kashgarian, M., and Ryan, J. L., 1983, Neutral proteinase activity produced in vitro by cells of the glomerular mesangium, Kidney Int. 23: 342–349.PubMedGoogle Scholar
  100. 100.
    Lovett, D. H., Ryan, J. L., and Sterzel, R. B., 1983, Stimulation of rat mesangial cell proliferation by macrophage interleukin 1, J. Immunol. 131: 2830–2836.PubMedGoogle Scholar
  101. 101.
    Lovett, D. H., Ryan, J. L., and Sterzel, R. B., 1983, A thymocyte-activating factor derived from glomerular mesangial cells, J. Immunol. 130: 1796 — 1801.PubMedGoogle Scholar
  102. 102.
    MacCarthy, E. P., Hsu, A., Ooi, Y. M., and Ooi, B. S.,1985, Evidence for a mouse mesangial cell-derived factor that stimulates lymphocyte proliferation, J. Clin. Invest. 76: 426–430.Google Scholar
  103. 103.
    Troyer, D. A., Kreisberg, J. I., Schwertz, D. W., and Venkatachalam, M. A., 1985, Effects of vasopressin on phosphoinositides and prostaglandin production in cultured mesangial cells, Am. J. Physiol. 249: F139–F147.PubMedGoogle Scholar
  104. 104.
    Paul, L. C., Rennke, H. G., Milford, E. L., and Carpenter, C. B., 1984, Thy-1.1 in glomeruli of rat kidneys, Kidney Int. 25: 771–777.PubMedGoogle Scholar
  105. 105.
    Tsumagari, T. and Tanaka, K., 1984, Effects of fibrinogen degradation products on glomerular mesangial cells in culture, Kidney Int. 26: 712–718.PubMedGoogle Scholar
  106. 106.
    Silva, F. G., Hoyer, J. R., and Pirani, C. L., 1984, Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors, Lab. Invest. 51: 404–415.PubMedGoogle Scholar
  107. 107.
    Holdsworth, S. R. and Tipping, P. G., 1984, Macrophage induced glomerular fibrin deposition, IXth International Congress of Nephrology, p. 243A (Abstr.).Google Scholar
  108. 108.
    Cole, E. H., Schulman, J., Urowitz, M., Keystone, E., Williams, C., and Levy, G. A., 1985, Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus, J. Clin. Invest. 75: 681–686.Google Scholar
  109. 109.
    Neilson, E. G. and Zakheim, B., 1983, T cell activation, anti-idiotypic immunity, and the nephritogenic immune response, Kidney Int. 24: 289–302.PubMedGoogle Scholar
  110. 110.
    Zakheim, B., McCafferty, E., Phillips, S. M., Clayman, M., and Neilson, E. G., 1984, Murine interstitial nephritis:II. The adoptive transfer of disease with immune T lymphocytes produces a phenotypically complex interstitial lesion, J. Immunol 133: 234–239.PubMedGoogle Scholar
  111. 111.
    Neilson, E. G., McCafferty, E., Mann, R., Michaud, L., and Clayman, M., 1985, Murine interstitial nephritis:III. The selection of phenotypic (Lyt and L3T4) and idiotypic (RE-ID) T cell preferences by genes in Igh-1 and H-2K characterizes the cell-mediated potential for disease expression: Susceptible mice provide a unique effector T cell repertoire in response to tubular antigen, J. Immunol 134: 2375–2382.PubMedGoogle Scholar
  112. 112.
    Mann, R., Zakheim, B., Clayman, M., McCafferty, E., Michaud, L. and Neilson, E. G., 1985, Murine interstitial nephritis: IV. Long-term cultured L3T4+ T cell lines transfer delayed expression of disease as I-A-restricted inducers of the effector T cell repertoire, J. Immunol 135: 286–293.PubMedGoogle Scholar
  113. 113.
    Neilson, E. G., McCafferty, E., Mann, R., Michaud, L., and Clayman, M., 1985, Tubular antigen-derivatized cells induced a disease-protective, antigen-specific, and idiotype specific suppressor T cell network restricted by I-J and Igh-V in mice with experimental interstitial nephritis, J. Exp. Med. 162: 215–230.PubMedGoogle Scholar
  114. 114.
    Clayman, M., Martinez-Hernandez, A., Michaud, L., Alper, R., Mann, R., Kefalides, N. A., and Neilson, E. G., 1985, Isolation and characterization of the nephritogenic antigen producing anti-tubular basement membrane disease, J. Exp. Med. 161: 290–305.PubMedGoogle Scholar
  115. 115.
    Neilson, E. G., McCafferty, E. Phillips, S. M., Clayman, M., and Kelly, C. J., 1984, Antiidiotypic immunity in interstitial nephritis:II. Rats developing anti-tubular basement membrane disease fail to make an antiidiotypic regulatory response: The modulatory role of an RT7.1+,OXB-suppressor T cell mechanism, J. Exp. Med. 159: 1009–1026.Google Scholar
  116. 116.
    Neilson, E. G., McCafferty, E., Feldman, A., Clayman, M., Zakhaim, B., and Korngold, R., 1984, Spontaneous interstitial nephritis in kdkd mice:I. An experimental model of autoimmune renal disease, J. Immunol 133: 2560–2565.PubMedGoogle Scholar
  117. 117.
    Mampaso, F. M., and Wilson, C. B., 1983, Characterization of inflammatory cells in autoimmune tubulointerstitial nephritis in rats, Kidney Int. 23: 448–457.PubMedGoogle Scholar
  118. 118.
    Bannister, K. M. and Wilson, C. B., 1985, Transfer of tubulointerstitial nephritis in the brown norway rat with anti-tubular basement membrane antibody: Quantitation and kinetics of binding and effect of decomplementation, J. Immunol 135: 3911–3916.PubMedGoogle Scholar
  119. 119.
    Ulich, R. T., Bannister, K. M., and Wilson, C. B., 1985, Tubulointerstitial nephritis induced in the Brown Norway rat with chaotropically solubilized bovine tubular basement membrane: The model and the humoral cellular responses, J. Med. 36: 187–200.Google Scholar
  120. 120.
    Colvin, R. B. and Olson, K. A., 1985, Idiotypes in autoimmune disease, Concepts Immunopathol. 1:133–172.Google Scholar
  121. 121.
    Nath, K. A., Hostetter, M. K., and Hostetter, T. H., 1985, Pathophysiology of chronic tubulo-interstitial disease in rats: Interactions of dietary acid load, ammonia, and complement component C3, J. Clin. Invest. 76: 667–675.PubMedGoogle Scholar
  122. 122.
    Reese, A. J., 1984, The HLA complex and susceptibility to glomerulonephritis, Plasma Ther. Transfus. Technol. 5: 455–470.Google Scholar
  123. 123.
    Rodriquez-Iturbe, B., 1984, Epidemic poststreptococcal glomerulonephritis, Kidney Int. 25: 129–136.Google Scholar
  124. 124.
    Seligson, G., Lange, K., Majeed, A., Deol, H., Cronin, W., and Bovie, R., 1985, Significance of endostreptosin antibody titers in poststreptococcal glomerulonephritis, Clin. Nephrol. 24: 69–75.PubMedGoogle Scholar
  125. 125.
    Friedman, J., van de Rijn, I., Ohkuni, H., Fischetti, V. A., and Zabriskie, J. B., 1984, Immunological studies of post-streptococcal sequelae: Evidence for presence of streptococcal antigens in circulating immune complexes, J. Clin. Invest. 74: 1027–1034.Google Scholar
  126. 126.
    Mosquera, J. and Rodriquez-Iturbe, B., 1984, Extracellular neuraminidase production of streptococci associated with acute nephritis, Clin. Nephrol. 21: 21–28.PubMedGoogle Scholar
  127. 127.
    Modai, D., Pik, A., Behar, M., Eidelman, A., Averbukh, Z., Weissgarten, J., Gabizon, D., and Rosenmann, E., 1985, Biopsy proven evolution of post streptococcal glomerulonephritis to rapidly progressive glomerulonephritis of a post infectious type, Clin. Nephrol. 23: 198–202.PubMedGoogle Scholar
  128. 128.
    Magil, A. B., 1984, Monocytes and glomerulonephritis associated with remote visceral infection, Clin. Nephrol. 22: 169–175.PubMedGoogle Scholar
  129. 129.
    Nebeker, H. G., Hercz, G., Feld, G. K., Stanley, T. M., Coburn, J. W., and Kurokawa, K., 1984, Postinfectious glomerulonephritis in a renal allograft associated with a mycotic aneurysm of a coronary artery, Am. J. Med. 76: 940–942.PubMedGoogle Scholar
  130. 130.
    Wakabayashi, Y., Kobayashi, Y., and Shigematsu, H., 1985, Shunt nephritis: Histological dynamics following removal of the shunt, Nephron 40: 111–117.PubMedGoogle Scholar
  131. 131.
    Neugarten, J., Gloria, R., Gallo, M. D., and Baldwin, D. S., 1984, Glomerulonephritis in bacterial endocarditis, Am. J. Kidney Dis. 3:371– 379.Google Scholar
  132. 132.
    Feinstein, E. I. and Eknoyan, G., 1985, Renal complications of bacterial endocarditis, Am. J. Nephrol. 5: 457–469.Google Scholar
  133. 133.
    Dubrow, A., Mittman, N., Ghali, V., and Flamenbaum, W., 1985, The changing spectrum of heroin-associated nephropathy, Am. J. Kidney Dis. 5: 36. 40.Google Scholar
  134. 134.
    Walker, P. D., Deeves, E. C., Sahba, G., Wallin, J. D., and O’Neill, W. M., 1984, Rapidly progressive glomerulonephritis in a patient with syphilis, Am. J. Med. 76: 1106–1112.PubMedGoogle Scholar
  135. 135.
    Ngu, J. L., Chatelanat, F., Leke, R., Ndumbe, P., and Youmbissi, J., 1985, Nephropathy in Cameroon: Evidence for filarial derived immune-complex pathogenesis in some cases, Clin. Nephrol. 24: 128–134.PubMedGoogle Scholar
  136. 136.
    Pakasa, M., Van Damme, B., and Desmet, V. J., 1985, Free intraglomerular malarial antigens, Br. J. Exp. Path. 66: 493–501.Google Scholar
  137. 137.
    Doehring, E., Ehrich, J. H. H., Vester, U., Feldmeier, H., Poggensee, U., and Brodehl, J., 1985, Proteinuria, hematuria, and leukocyturia in children with mixed urinary and intestinal schistosomiasis, Kidney Int. 28: 520–525.PubMedGoogle Scholar
  138. 138.
    Doehring, E., Vester, U., Enrich, J. H. H., and Feldmeier, H., 1985, Orcadian variadon of ova excretion, proteinuria, hematuria, and leukocyturia in urinary schistosomiasis, Kidney Int. 27: 667–671.PubMedGoogle Scholar
  139. 139.
    Pardo, V., Aldana, M, Colton, R. M., Fischl, M. A., Jaffe, D., Moskowitz, L., Hensley, G. T., and Bourgoignie, J. J., 1984, Glomerular lesions in the acquired immunodeficiency syndrome, Ann. Intern. Med. 101: 429–434.PubMedGoogle Scholar
  140. 140.
    Gardenswartz, M. H., Lerner, C. W., Seligson, G. R., Zabetakis, P. M., Rotterdam, H., Tapper, M. L., Michelis, M. F., and Bruno, M. S., 1984, Renal disease in patients with AIDS: A clinicopathologic study, Clin. Nephrol. 21: 197–204.PubMedGoogle Scholar
  141. 141.
    Sreepada Rao, T. K., Filippone, E. J., Nicastri, A. D., Landesman, S. H., Frank, E., Chen, C. K., and Friedman, E. A., 1984, Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome, N. Engl. J. Med. 310: 669–673.Google Scholar
  142. 142.
    Singer, D. R. J., Jenkins, A. P., Gupta, S., and Evans, D. J., 1985, Minimal change nephropathy in the acquired immune deficiency syndrome, Br. Med. J. 291: 868.Google Scholar
  143. 143.
    Seek, M., Weber, D. J., and Mattern, W. D., 1985, AIDS, renal disease and dialysis, Nephrol. Lett. 2: 29–36.Google Scholar
  144. 144.
    Lawley, T. J., Bielory, L., Gascon, P., Yancey, K. B., Young, N. S., and Frank, M. M., 1984, A prospective clinical and immunologic analysis of patients with serum sickness, N. Engl. J. Med. 311: 1407–1413.PubMedGoogle Scholar
  145. 145.
    Power, D. A., Murhead, N., Simpson, J. G., Nicholls, A. J., Home, C. H. W., Catto, G. R. D., and Edward, N., 1985, IgA nephropathy is not a rare disease in the United Kingdom, Nephron 40: 180–184.PubMedGoogle Scholar
  146. 146.
    Couser, W. G., 1984, Mesangial IgA nephropathies-steady progress, West. J. Med. 140: 89–91.PubMedGoogle Scholar
  147. 147.
    Emancipator, S. N., Gallo, G. R., and Lamm, M. E., 1985, IgA nephropathy: Perspectives on pathogenesis and classification, Clin. Nephrol. 24: 161–179.PubMedGoogle Scholar
  148. 148.
    Egido, J., Sancho, J., Blasco, R., Rivera, F., and Hernando, L., 1983, Immunopathogenetic aspects of IgA nephropathy, Adv. Nephrol. 12: 103–137.Google Scholar
  149. 149.
    Andres, P., 1984, Brief communications: IgA-IgG disease in the intestine of Brown-Norway rats ingesting mercuric chloride, Clin. Immunol. Immunopathol. 30: 488–494.PubMedGoogle Scholar
  150. 150.
    Imai, H., Nakamoto, Y., Asakura, K., Mike, K., Yasuda, T., and Miura, A. B., 1985, Spontaneous glomerular IgA deposition in ddY mice: An animal model of IgA nephritis, Kidney Int. 27: 756–761.PubMedGoogle Scholar
  151. 151.
    Hale, G. M., Mcintosh, S. L., Hiki, Y., Clarkson, A. R., and Woodroffe, A. J., 1986, Evidence for IgA-specific B cell hyperactivity in patients with IgA nephropathy, Kidney Int. 29: 718–724.PubMedGoogle Scholar
  152. 152.
    Egido, J., Blasco, R., Lozano, L., Sancho, J., and Garcia-Hoyo, R., 1984, Immunological abnormalities in the tonsils of patients with IgA nephropathy: Inversion in the ratio of IgA: IgG bearing lymphocytes and increased polymeric IgA synthesis, Clin. Exp. Immunol. 57: 101–106.PubMedGoogle Scholar
  153. 153.
    Rothschild, E. and Chatenoid, L., 1984, T cell subset modulation of immunoglobulin production in IgA nephropathy and membranous glomerulonephritis, Kidney Int. 25: 557–564.PubMedGoogle Scholar
  154. 154.
    Egido, J., Blasco, R. A., Sancho, J., and Hernando, L., 1985, Immunological abnormalides in healthy relatives of patients with IgA nephropathy, Am. J. Nephrol. 5: 14–20.PubMedGoogle Scholar
  155. 155.
    Monteiro, R. C., Halbwachs-Mecarelli, L., Roque-Barreira, M. C., Noel, L. H., Berger, J., and Lesavre, P., 1985. Charge and size of mesangial IgA in IgA nephropathy, Kidney Int. 28: 666–671.PubMedGoogle Scholar
  156. 156.
    Valentijn, R. M., Radl, J., Haaijaman, J. J., Vermeer, B. J., Weening, J. J., Kauffmann, R. H., Daha, M. R., and van Es, L. A., 1984, Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy, Kidney Int. 26: 760–766.PubMedGoogle Scholar
  157. 157.
    Melvin, T. R., Kim, Y., Conley, M. E., Delacroix, D. L., and Michael, A. F., 1985, Hidden IgA subclass determinants in human renal disease, Kidney Int. 27: 685–689.PubMedGoogle Scholar
  158. 158.
    Miyazadi, R., Kuroda, M., Akiyama, T., Otani, I., Tofuku, Y., and Takeda, R., 1984, Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy, Clin. Nephrol. 21: 335–340.Google Scholar
  159. 159.
    Doi, T., Kanatsu, K., Nagai, H., Kohrogi, N., Kuwahara, T., and Hamashima, Y., 1984, Immunoelectron microscopic studies of IgA nephropathy, Nephron 36: 246–251.PubMedGoogle Scholar
  160. 160.
    Nagy, J., Uj, M., Szucs, G., Trinn, Cs. and Burger, T., 1984, Herpes virus antigens and antibodies in kidney biopsies and sera of IgA glomerulonephritic patients, Clin. Nephol. 21: 259–262.Google Scholar
  161. 161.
    Tomino, Y., Sakai, H., Miura, M., Suga, T., Endoh, M., Nomoto, Y., Umehara, K., and Hashimoto, K., 1985, Specific binding of circulating IgA antibodies in patients with IgA nephropathy, Am. J. Kidney Dis. 6: 149–152.PubMedGoogle Scholar
  162. 162.
    Egido, J., Sancho, J., Rivera, F., and Hernando, L., 1984, The role of IgA and IgG immune complexes in IgA nephropathy, Nephron 36: 52–59.PubMedGoogle Scholar
  163. 163.
    Nicholls, K. and Kincaid-Smith, P., 1984, Defective in vivo Fcand C3breceptor function in IgA nephropathy, Am. J. Kidney Dis. 4: 128–134.PubMedGoogle Scholar
  164. 164.
    Roccatello, D., Coppo, R., Piccoli, G., Cordonnier, D., Martina, G., Rollino, C., Picciotto, G., Sena, L. M., and Amorosa, A., 1985, Circulating Fcreceptor blocking factors in IgA nephropathies, Clin. Nephrol. 23: 159–168.PubMedGoogle Scholar
  165. 165.
    Hulette, C. and Carstens, P. H. B., 1985, Electron-dense deposits in extraglomerular vascular structures in IgA nephropathy, Nephron 39: 179–183.PubMedGoogle Scholar
  166. 166.
    Endo, Y. and Hara, M., 1986, Glomerular IgA deposition in pulmonary diseases, Kidney Int. 29: 557–562.PubMedGoogle Scholar
  167. 167.
    Cohen, A. J. and Rosenstein, E. D., 1985, IgA nephropathy associated with disseminated tuberculosis, Arch. Intern. Med. 145: 554–556.PubMedGoogle Scholar
  168. 168.
    Jennette, J. C., Wall, S. D., and Wilkman, A. S., 1985, Low incidence of IgA nephropathy in blacks, Kidney Int. 28: 944–950.PubMedGoogle Scholar
  169. 169.
    Smith, S. M. and Tung, K. S. K., 1984, Incidence of IgA-related nephritides in American Indians in New Mexico, Hum. Pathol. 16: 181–184.Google Scholar
  170. 170.
    McLean, R. H., Wyatt, R. J., and Julian, B. A., 1984, Complement phenotypes in glomerulonephritis: Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schonlein purpura, Kidney Int. 26: 855–860.PubMedGoogle Scholar
  171. 171.
    Julian, B. A., Quiggins, P. A., Thompson, J. S., Woodford, S. Y., Gleason, K., and Wyatt, R. J., 1985, Familial IgA nephropathy: Evidence of an inherited mechanism of disease, N. Engl. J. Med. 312: 202–208.PubMedGoogle Scholar
  172. 172.
    Nomoto, Y., Endoh, M., Miura, M., Tomino, Y., Sakai, H., Nose, Y., and Tsuji, K., 1984, IgA nephropathy associated with HLA-DR4 antigen, Am. J. Nephrol. 4: 184 - 187.PubMedGoogle Scholar
  173. 173.
    Nicholls, K. M., Fairley, K. F., Dowling, J. P., and Kincaid-Smith, P., 1984, The clinical course of mesangial IgA associated nephropathy in adults, Q. J. Med. 210: 227–250.Google Scholar
  174. 174.
    Nicholls, K., Walker, R. G., Dowling, J. P., and Kincaid-Smith, P., 1985, “Malignant” IgA nephropathy, Am. J. Kidney Dis. 5: 42–46.PubMedGoogle Scholar
  175. 175.
    Feltis, J. T., Churg, J., Holley, K. M., Feiner, H., Gallo, G., and Ackad, A. S., 1984, Active and chronic phases of Berger’s disease (IgA nephrology), Am. J. Kidney Dis. 3: 349–356.PubMedGoogle Scholar
  176. 176.
    Clarkson, A. R., Woodroffe, A. J., Bannister, K. M., Lomax-Smith, J. D., and Arrons, I., 1984, The syndrome of IgA nephropathy, Clin. Nephrol. 21: 7–14.PubMedGoogle Scholar
  177. 177.
    Rodico, J. L., 1984, Idiopathic IgA nephropathy, Kidney Int. 25: 717–729.Google Scholar
  178. 178.
    Beukhof, J. R., Ockhuizen, Th., Halie, L. M., Westra, J., Beelen, J. M., Donker, A. J. M., Hoedemaeker, Ph. J., and van der Hem, G. K., 1984, Subentities within adult primary IgA-nephropathy, Clin. Nephrol. 22: 195–199.PubMedGoogle Scholar
  179. 179.
    Abuelo, J. G., Esparza, A. R., Matarese, R. A., Endreny, R. G., Carvalho, J. S., and Allegra, S. R., 1984, Crescentic IgA nephropathy, Medicine 63: 396–406.PubMedGoogle Scholar
  180. 180.
    Wyatt, R. J., Julian, B. A., Bhathena, D. B., Mitchell, B. L., Holland, N. H., and Malluche, H., 1984, IgA nephropathy: Presentation, clinical course, and prognosis in children and adults, Am. J. Kidney Dis. 1: 192–200.Google Scholar
  181. 181.
    Sinniah, R., 1985, IgA Mesangial nephropathy: Berger’s disease, Am. J. Nephrol. 5: 73–83.PubMedGoogle Scholar
  182. 182.
    Mustonen, J., Pasternack, A., Helin, H., and Nikkila, M., 1985, Clinicopathologic correlations in a series of 143 patients with IgA glomerulonephritis, Am. J. Nephrol. 5: 150–157.PubMedGoogle Scholar
  183. 183.
    Lai, K. N., Ho, C. P., Chan, K. W., Yan, K. W., Mac-Moune Lai, F., and Vallance-Owen, J., 1985, Nephrotic range proteinuria—A good predictive index of disease in IgA nephropathy, Q. J. Med. 57: 677–688.PubMedGoogle Scholar
  184. 184.
    Amico, G. D., 1985, Idiopathic IgA mesangial nephropathy, Nephron 41: 1–13.PubMedGoogle Scholar
  185. 185.
    Levy, M., Gonzalez-Burchard, G., Broyer, M., Dommergues, J. P., Fouland, M., Sorez, J. P., and Habib, R., 1985, Berger’s disease in children, Medicine 64: 157–180.PubMedGoogle Scholar
  186. 186.
    Mina, S. N. and Murphy, W. M., 1985, IgA nephropathy, Am. J. Clin. Pathol. 83: 669 - 675.PubMedGoogle Scholar
  187. 187.
    Glassock, R. J., ed., 1985, Nephrology Consultant, IgA nephropathy in Japan, Am. J. Nephrol. 5:127–137.Google Scholar
  188. 188.
    Hattori, S., Karashima, S., Furuse, A., Terashima, T., Hiramatsu, M., Murakami, M., and Matsuda, I., 1985, Clinicopathological correlation of IgA nephropathy in children, Am. J. Nephrol. 5: 182–189.PubMedGoogle Scholar
  189. 189.
    Southwest Pediatric Nephrology Study Group, 1985, Association of Iga Nephropathy with steroid-responsive nephrotic syndrome, Am. J. Kidney Dis. 5: 157–164.Google Scholar
  190. 190.
    Woo, K. T., Edmondson, R. P. S., Wu, A. Y. T., Chiang, G. S. C., Pwee, H. S., and Lim, C. H., 1986, The natural history of Iga Nephritis in Singapore, Clin. Nephrol. 25: 15–21.PubMedGoogle Scholar
  191. 191.
    Chida, Y., Tomura, S., and Takeuchi, 1985, Renal survival rate of IgA nephropathy, Nephron 40: 189–194.PubMedGoogle Scholar
  192. 192.
    Bennett, W. M. and Kincaid-Smith, P., 1983, Macroscopic hematuria in mesangial IgA nephropathy: Correlation with glomerular crescents and renal dysfunction, Kidney Int. 23: 393–400.PubMedGoogle Scholar
  193. 193.
    Praga, M., Gutierrez-Millet, V., Navas, J. J., Ruilope, L. M., Morales, J. M., Alcazar, J. M., Bello, I., and Rodico, J. L., 1985, Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy, Kidney Int. 28: 69–74.PubMedGoogle Scholar
  194. 194.
    Coppo, R., Basolo, B., Giachino, O., Roccdtello, d., Lajolo, D., Mazzucco, G., Amore, A., and Piccoli, G., 1985, Plasmapheresis in a patient with rapidly progressive idiopathic IgA nephropathy: Removal of IgA-containing circulating immune complexes and clinical recovery, Nephron 40: 488–490.PubMedGoogle Scholar
  195. 195.
    Abreo, K. and Wen, S. F., 1983, A case of Iga nephropathy with an unusual response to corticosteroid and immunosuppressive therapy, Am. J. Kidney Dis. 3: 54–57.PubMedGoogle Scholar
  196. 196.
    Wu, G., Katz, A., Cardella, C., and Oreopoulos, D. G., 1985, Spontaneous remission of nephrotic syndrome of IgA glomerular disease, Am. J. Kidney Dis. 6: 96–99.PubMedGoogle Scholar
  197. 197.
    Sinnassamy, P. and O’Regan, S., 1985, Mesangial IgA deposits with steroid responsive nephrotic syndrome: Probable minimal lesion nephrosis, Am. J. Kidney Dis. 5: 267–269.PubMedGoogle Scholar
  198. 198.
    Egido, J., Rivera, F., Sancho, J., Barat, A., and Hernando, L., 1984, Phenytoin in IgA nephropathy: A long-term controlled trial, Nephron 38: 30–39.PubMedGoogle Scholar
  199. 199.
    Coppo, R., Basolo, B., Roccatello, D., Giachino, O., Lajolo, D., Martina, G., Rollini, C., Amore, A., Costa, M., and Piccoli, G., 1985, Immunological monitoring of plasma exchange in primary IgA nephropathy, Artif. Organs 9: 351–360.PubMedGoogle Scholar
  200. 200.
    Coppo, R., Basolo, B., Giachino, O., Roccdtello, D., Lajolo, D., Mazzucco, G., Amore, A., and Piccoli, G., 1985, Plasmapheresis in a patient with rapidly progressive idiopathic IgA nephropathy: Removal of IgA-containing circulating immume complexes and clinical recovery, Nephron 40: 488–490.PubMedGoogle Scholar
  201. 201.
    Tomino, Y., Sakai, H., Miura, M., Suga, T., Endoh, M., and Nomoto, Y., 1984, Effect of danazol on solubilization of immune deposits in patients with IgA nephropathy, Am. J. Kidney Dis. 4: 135–140.PubMedGoogle Scholar
  202. 202.
    Walshe, J. J., Brentjens, J. R., Costa, G. G., Andres, G. A., and Venuto, R. C., 1984, Abdominal pain associated with IgA nephropathy, Am. J. Med. 77: 765–767.PubMedGoogle Scholar
  203. 203.
    Hasbargen, J. A. and Copley, J. B., 1985, Utility of skin biopsy in the diagnosis of IgA nephropathy, Am. J. Kidney Dis. 6: 100–102.PubMedGoogle Scholar
  204. 204.
    Couser, W. G., 1982, Rapidly progressive glomerulonephritis (Editorial Review), Am. J. Nephrol. 2: 57–69.PubMedGoogle Scholar
  205. 205.
    Couser, W. G., 1985, Glomerular Diseases, in: CecilsTextbook of Medicine, 17th edi., (J. B. Wyngaarden and L. H. Smith, Jr., eds), Saunders, Philadelphia, Chapter 80, pp. 568–588.Google Scholar
  206. 206.
    Rawachi, H., Oite, T., and Shimizu, F., 1985, Studies on the “linear pattern” in renal glomeruli demonstrated with immunofluorescence, Nephron 39: 36–39.Google Scholar
  207. 207.
    Bernis, P., Hamels, J., Quoidbach, A., Mahieu, P., and Bouvy, P., 1985, Remission of Goodpasture’s syndrome after withdrawal of an unusual toxin, Clin. Nephrol 23: 312–317.PubMedGoogle Scholar
  208. 208.
    Ravnskov, U., 1985, Possible mechanisms of hydrocarbon-associated glomerulonephritis, Clin. Nephrol 23: 294–298.PubMedGoogle Scholar
  209. 209.
    Fish, A. J., Kleppel, M., Jeraj, K., and Michael, A. F., 1985, Enzyme immunoassay of anti-glomerular basement membrane antibodies, J. Lab. Clin. Med. 105: 770–705.Google Scholar
  210. 210.
    Donaghy, M. and Rees, A. J., 1983, Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane, Lancet 2: 1390–1394.PubMedGoogle Scholar
  211. 211.
    Rees, A. J., Peters, D. K., Amos, N., Welsh, K. I., and Batchelor, J. R., 1984, The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritis, Kidney Int. 26: 444–450.Google Scholar
  212. 212.
    Pusey, C. D., Lockwood, C. M., Peters, D. K., 1983, Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane, Int. J. Artif. Organs 6: 15–18.PubMedGoogle Scholar
  213. 213.
    Hind, C. R. K., Lockwood, C. M., Peters, D. K., Paraskevadou, H., Evans, D. J., and Reese, A. J., 1983, Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis, Lancet 1: 263–266.PubMedGoogle Scholar
  214. 214.
    Johnson, J. P., Moore, J., Austin, H. A., Balow, J. E., Antonovych, T. T., and Wilson, C. B., 1985, Therapy of anti–glomerular basement membrane antibody disease: Analysis of prognostic significance of clinical pathologic and treatment factors, Medicine 64: 219–227.PubMedGoogle Scholar
  215. 215.
    Walker, R. G., Scheinkestel, C., Becker, G. J., Owen, J. E., Dowling, J. P., and Kincaid-Smith, P., 1985, Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture’s syndrome, Q. J. Med. 54: 75–89.Google Scholar
  216. 216.
    Hind, C. R. K., Bowman, C., Winearls, C. G., and Lockwood, C. M., 1984, Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange, Clin. Nephrol 21: 244–246.PubMedGoogle Scholar
  217. 217.
    Boyce, N., Holdsworth, S., Atkins, R., and Dowling, J., 1985, De-novo antiGBM-antibody-induced glomerulonephritis in a renal transplant, Clin. Nephrol 23: 148–151.Google Scholar
  218. 218.
    Querin, S., Hoel, L. H., Grunfeld, J. P., Droz, D., Mathieu, P., Berger, J., and Kreis, H., 1986, Linear glomerular IgG fixation in renal allografts: Incidence and significance in Alport’s syndrome, Clin. Nephrol 25: 134–140.PubMedGoogle Scholar
  219. 219.
    Leatherman, J. W., Davies, S. F., and Hoidal, J. R., 1984, Alveolar hemorrhage syndromes: Diffuse microvascular lung hemorrhage in immune and idiopathic disorders, Medicine 63: 343–361.PubMedGoogle Scholar
  220. 220.
    Magil, A. B., 1985, Immunohistochemical demonstration of cytokeratin in crescent cells, Am. J. Pathol. 120: 222–229.PubMedGoogle Scholar
  221. 221.
    Balow, J. E., 1985, Renal vasculitis, Kidney Int. 27: 954–964.PubMedGoogle Scholar
  222. 222.Kingswood, J. C., Banks, R. A., Tribe, C. R., Owen-Jones, J., and Mackenzie, J. C., 1984, Renal biopsy in the elderly: Clinicopathological correlations in 143 patients, Clin. Nephrol. 22: 183–187.Google Scholar
  223. 223.
    Abrass, C. K., 1985, Glomerulonephritis in the elderly, Am. J. Nephrol. 5: 409–418.PubMedGoogle Scholar
  224. 224.
    Sadjadi, S. A., Seelig, M. S., Berger, A. R., and Milstoc, M., 1985, Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine, Am. J. Nephrol. 5: 212–216.PubMedGoogle Scholar
  225. 225.
    Leung, A. C. T., McLay, A., Dobbie, J. W., and Jones, J. M. B., 1985, Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis, Arch. Intern. Med. 145: 685–687.PubMedGoogle Scholar
  226. 226.
    Wegmuller, E., Weidmann, P., Hess, T., and Reubi, F. C., 1985, Rapidly progressive glomerulonephritis accompanying Legionnaires’ disease, Arch. Intern. Med. 145: 1711–1713.PubMedGoogle Scholar
  227. 227.
    Meyrier, A., Simon, P., Mignon, F., Striker, L., and Ramme, M. P., 1984, Rapidly progressive (“crescentic”) glomerulonephritis and monoclonal gammapathies, Nephron 38: 156–162.PubMedGoogle Scholar
  228. 228.
    Kebler, R., Kithier, K., McDonald, F. D., and Cadnapaphornchai, P., 1985, Rapidly progressive glomerulonephritis and monoclonal gammopathy, Am. J. Med. 78: 133–138.PubMedGoogle Scholar
  229. 229.
    Bell, G. M., Gordon, A. C. H., Lee, P., Doig, A., MacDonald, M. K., Thomson, D., Anderton, J. L., and Robson, J. S., 1985, Proliferative glomerulonephritis and exposure to organic solvents, Nephron 40: 161–165.PubMedGoogle Scholar
  230. 230.
    Biava, C. G., Gonwa, T. A., Naughton, J. L., and Hopper, J., 1984, Crescentic glomerulonephritis associated with nonrenal malignancies, Am. J. Nephrol. 4: 208–214.PubMedGoogle Scholar
  231. 231.
    Southwest Pediatric Nephrology Study Group, 1985, A clinico-pathologic study of crescentic glomerulonephritis in 50 children, Kidney Int. 27: 450–458.Google Scholar
  232. 232.
    Balow, J. E., Austin, H. A., and Tsokos, G. C., 1984, Plasmapheresis therapy in immunologically mediated rheumatic and renal diseases, Clin. Immunol. Rev. 3: 235–272.PubMedGoogle Scholar
  233. 233.
    Bolton, W. K., 1984, Use of pulse methylprednisolone in primary and multisystem glomerular diseases, in: Nephrology, Volume 2, Proceedings of the IXth International Congress of Nephrology (R. R. Robinson, ed.), Springer Verlag, New York, pp. 1464–1473.Google Scholar
  234. 234.
    Pusey, C. D. and Lockwood, C. M., 1984, Plasma exchange for glomerular disease, in: Nephrology, Volume 2, Proceedings IXth International Congress of Nephrology (R. R. Robinsin, Ed.), Springer Verlag, New York, pp. 1474–1485.Google Scholar
  235. 235.
    Müller, G. A., Gebhardt, M., Kompf, J., Baldwin, W. M., Ziegenhagen, D., and Bohle, A., 1984, Association between rapidly progressive glomerulonephritis and the properdin factor BfF and different HLA-D region products, Kidney Int. 25: 115–118.PubMedGoogle Scholar
  236. 236.
    Glassock, R. J., 1985, Natural history and treatment of primary proliferative glomerulonephritis: A review, Kidney Int. 28: S136–S142.Google Scholar
  237. 237.
    Glassock, R. J., Cohen, A. H., Adler, S., and Ward, H., 1986, Primary Glomerular Diseases, in; The Kidney, 3rd ed. (B. M. Brenner and F. C. Rector, Jr., eds) Saunders, Philadelphia, Chapter 22, pp. 929–1013.Google Scholar
  238. 238.
    Levin, M., Smith, C., Walters, M. D. S., Gascoine, P., and Barratt, T. M., 1985, Steroid-responsive nephrotic syndrome: A generalised disorder of membrane negative charge, Lancet 1: 239–242.Google Scholar
  239. 239.
    Shemesh, O., Ross, J. C., Deen, W. M., Grant, G. W., and Myers, B. D., 1986, Nature of the glomerular capillary injury in human membranous glomerulopathy, J. Clin. Invest. 77: 868–877.PubMedGoogle Scholar
  240. 240.
    Brown, E. A., Markandu, N., Sagnella, G. A., Jones, B. E., and MacGregor, G. A., 1985, Sodium retention in nephrotic syndrome is due to an intrarenal defect: Evidence from steroid-induced remission, Nephron 39: 290–295.PubMedGoogle Scholar
  241. 241.
    Geers, A. B., Koomans, H. A., Roos, J. C., Boer, P., and Dorhout Mees, E. J., 1984, Functional relationships in the nephrotic syndrome, Kidney Int. 26: 324–330.PubMedGoogle Scholar
  242. 242.
    Hammond, T. G., Whitworth, J. A., Saines, D., Thatcher, R., Andrews, J., and Kincaid-Smith, P., 1984, Renin-angiotensin-aldosterone system in nephrotic syndrome, Am. J. Kidney Dis. 4: 18–22.PubMedGoogle Scholar
  243. 243.
    Geers, A. B., Koomans, H. A., Boer, P., and Dorhout Mees, E. J., 1984, Plasma and blood volumes in patients with the nephrotic syndrome, Nephron 38: 170–173.PubMedGoogle Scholar
  244. 244.
    Bohlin, A-B. and Berg, U., 1984, Renal sodium handling in minimal change nephrotic syndrome, Arch. Dis. Child. 59: 825–830.PubMedGoogle Scholar
  245. 245.
    Cumming, A. D. and Robson, J. S., 1985, Urinary kallikrein excretion in glomerulonephritis and nephrotic syndrome, Nephron 39: 206–210.PubMedGoogle Scholar
  246. 246.
    Dorhout Mees, E. J., Geers, A. B., and Koomans, H. A., 1984, Blood volume and sodium retention in the nephrotic syndrome: A controversial pathophysiological concept, Nephron 36: 201–211.PubMedGoogle Scholar
  247. 247.
    Strauss, J., Freundlich, M., and Zilleruelo, G., 1984, Nephrotic edema: Etiopathogenic and therapeutic considerations, Nephron 38: 73–75.PubMedGoogle Scholar
  248. 248.
    Bohman, S-O., Jaremko, G., Bohlin, A-B., Berg, U., 1984, Foot process fusion and glomerular filtration rate in minimal change nephrotic syndrome, Kidney Int. 25: 696–700.PubMedGoogle Scholar
  249. 249.
    Usberti, M., Federico, S., Meccariello, S., Cianciaruso, B., Balletta, M., Pecoraro, C., Sacca, L., Ungaro, B., Pisanti, N., and Andreucci, V. E., 1984, Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome, Kidney Int. 25: 422–429.PubMedGoogle Scholar
  250. 250.
    Kaysen, G. A., Kirkpatrick, W. G., and Couser, W. G., 1984, Albumin homeostasis in the nephrotic rat: Nutritional considerations, Am. J. Physiol. 16.-F192–F202.Google Scholar
  251. 251.
    Appel, G. B., Glum, C. B., Chien, S., Kunis, C. L., and Appel, A. S., 1985, The hyperlipidemia of the nephrotic syndrome, N. Engl. J. Med. 312: 1544–1548.PubMedGoogle Scholar
  252. 252.
    Vaziri, N. D., Toohey, J., Paule, P., Hung, E., Darwish, R., Barton, C. H., and Alikhani, SM., 1984, Urinary excretion and deficiency of prothrombin in nephrotic syndrome, Am. J. Med. 77: 433–436.PubMedGoogle Scholar
  253. 253.
    Tomura, S., Oono, Y., Kuriyama, R., and Takeuchi, J., 1985, Plasma concentrations of fibrinopeptide A and fibrinopeptide B 15–42 in glomerulonephritis and the nephrotic syndrome, Arch. Intern. Med. 145: 1033–1035.PubMedGoogle Scholar
  254. 254.
    Schieppati, A., Dodesini, P., Benigni, A., Massazza, M., Mecca, G., Remuzzi, G., Livio, M., De Gaetano, G., and Rossi, E. C., 1984, The metabolism of arachidonic acid by platelets in nephrotic syndrome, Kidney Int. 25: 671–676.PubMedGoogle Scholar
  255. 255.
    Llach, F., 1985, Hypercoagulability, renal vein thrombosis and other thrombotic complications of nephrotic syndrome, Kidney Int. 28: 429–439.PubMedGoogle Scholar
  256. 256.
    Alon, U. and Chan, J. C. M., 1984, Calcium and vitamin D homeostasis in the nephrotic syndrome: Current status, Nephron 36: 1–4.PubMedGoogle Scholar
  257. 257.
    Matsumoto, K., Osakabe, Katayama, H., Okano, K., Watanabe, S., and Hatano, M., 1984, Impaired delayed hypersensitivity in lipoid nephrosis, Nephron 37: 273–275.Google Scholar
  258. 258.
    Matsumoto, K., and Hatano, M., 1985, Depression of local graft-versus-host reaction in patients with lipoid nephrosis, J. Clin. Lab. Immunol. 17: 137–141.PubMedGoogle Scholar
  259. 259.
    Matsumoto, K., Okano, K., Yoshizawa, N., Harada, M., Ohi, H., and Hatano, M., 1985, Impaired T-lymphocyte colony formation in lipoid nephrosis, Clin. Nephrol. 24: 279–284.PubMedGoogle Scholar
  260. 260.
    Taube, D., Brown, Z., and Williams, D. G., 1984, Impaired lymphocyte and suppressor cell function in minimal change nephropathy, membranous nephropathy and focal glomerulosclerosis, Clin. Nephrol. 22: 176–182.PubMedGoogle Scholar
  261. 261.
    Tomizawa, S., Maruyama, K., Nagasawa, N., Suzuki, S., and Kuroume, T., 1985, Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome, Nephron 41: 157–160.PubMedGoogle Scholar
  262. 262.
    Nagata, K., Piatt, J. L., and Michael, A. F., 1984, Interstitial and glomerular immune cell populations in idiopathic nephrotic syndrome, Kidney Int. 25: 88–93.PubMedGoogle Scholar
  263. 263.
    Feinfeld, D. A., Olesnicky, L., Pirani, C. L., and Appel, G. B., 1984, Nephrotic syndrome associated with use of the nonsteroidal anti-inflammatory drugs, Nephron 37: 174–179.PubMedGoogle Scholar
  264. 264.
    Abt, A. B. and Gordon, J. A., 1985, Drug-induced interstitial nephritis: Coexistence with glomerular disease, Arch. Intern. Med. 145: 1063–1067.PubMedGoogle Scholar
  265. 265.
    Fellner, S. K., 1985, Piroxicam-induced acute interstitial nephritis and minimal-change nephrotic syndrome, Am. J. Nephrol. 5: 142–143.PubMedGoogle Scholar
  266. 266.
    Averbuch, S. D., Austin, H. A., Sherwin, S. A., Antonovych, T., Bunn, P. A., and Longo, D. L., 1984, Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte A interferon therapy for mycosis fungoides, N. Engl. J. Med. 310: 31–36.Google Scholar
  267. 267.
    Selby, P., Kohn, J., Raymond, J., Judson, I., and McElwain, T., 1985, Nephrotic syndrome during treatment with interferon, Br. Med. J. 290: 1180–1184.Google Scholar
  268. 268.
    Kobayashi, Y., Chen, X.-M., Hiki, Y., Fujii, K., and Kashiwagi, N., 1985, Association of HLA-DRw8 and DQw3 with minimal change nephrotic syndrome in Japanese adults, Kidney Int. 28: 193–197.PubMedGoogle Scholar
  269. 269.
    Geary, D., Thorner, P., Arbus, G. S., and Baumal, R., 1985, Minimal lesion disease followed by membranous glomerulonephritis in two children with nephrotic syndrome, Clin. Nephrol. 23: 258–264.PubMedGoogle Scholar
  270. 270.
    Pru, C., Kjellstrand, C. M., Cohn, R. A., and Vernier, R. L., 1984, Late recurrence of minimal lesion nephrotic syndrome, Ann. Intern. Med. 100: 69–72.PubMedGoogle Scholar
  271. 271.
    Sharpies, P. M., Poulton, J., and White, R. H. R., 1985, Steroid responsive nephrotic syndrome is more common in Asians, Arch. Dis. Child. 60: 1014–1017.Google Scholar
  272. 272.
    Tejani, A., 1985, Morphological transition in minimal change nephrotic syndrome, Nephron 39: 157–159.PubMedGoogle Scholar
  273. 273.
    Habib, R. and Chutg, J., 1984, Minimal change disease, mesangial proliferative glomerulonephritis and focal sclerosis: Individual entities or a spectrum of disease? in: Nephrology, Volume 1., Proceedings of the IXth International Congress of Nephrology ( R. R. Robinson, ed.), Springer Verlag, New York, pp. 634–644.Google Scholar
  274. 274.
    Cohen, A. H., Border, W. A., and Glassock, R. J., 1978, Nephrotic syndrome with mesangial IgM deposits, Lab. Invest. 38: 610–617.PubMedGoogle Scholar
  275. 275.
    Pardo, V., Riesgo, I., Zilleruelo, G., and Strauss, J., 1984, The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome, Am. J. Kidney Dis. 3: 264–269.PubMedGoogle Scholar
  276. 276.
    Gonzalo, A., Mampaso, F., Gallego, N., Quereda, C., Fierro, C., and Ortuno, J., 1985, Clinical significance of IgM mesangial deposits in the nephrotic syndrome, Nephron 41: 246–249.PubMedGoogle Scholar
  277. 277.
    Ji-Yun, Y., Melvin, T., Sibley, R., and Michael, A. F., 1984, No evidence for a specific role of IgM in mesangial proliferationof idiopathic nephrotic syndrome, Kidney Int. 25: 100–106.PubMedGoogle Scholar
  278. 278.
    Aubert, J., Humair, L., Chatelanat, F., and de Torrente, A., 1985, IgMassociated mesangial proliferative glomerulonephritis and focal and segmental hyalinosis with nephrotic syndrome, Am. J. Nephrol. 5: 445–449.Google Scholar
  279. 279.
    Hirszel, P., Yamase, H. T., Carney, W. R., Galen, M. A., Graeber, C. W., Johnson, K. J., Kennedy, T. L., Lapkin, R. A., McLean, R. H., Rosenworcel, E., and Rowett, D. A., 1984, Mesangial proliferative glomerulonephritis with IgM deposits: Clinicopathologic analysis and evidence for morphologic transitions, Nephron 38: 100–108.PubMedGoogle Scholar
  280. 280.
    Jennette, J. C. and Hipp, C. G., 1985, Clq nephropathy: A distinct pathologic entity usually causing nephrotic syndrome, Am. J. Kidney Dis. 6: 103–110.PubMedGoogle Scholar
  281. 281.
    Anderson, S., Meyer, T. W., Rennke, H. G., and Brenner, B. M., 1985, Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass, J. Clin. Invest. 76: 612–619.PubMedGoogle Scholar
  282. 282.
    Striker, L. M-M., Killen, P. D., Chi, E., and Striker, G. E., 1984, The composition of glomerulosclerosis, Lab. Invest. 51: 181–192.PubMedGoogle Scholar
  283. 283.
    Bruneval, P., Foidart, J.\M., Nochy, D., Camilleri, J. P., and Bariety, J., 1984, Glomerular matrix proteins in nodular glomerulosclerosis in association with light chain deposition disease and diabetes mellitus, Hum. Pathol. 16: 477–484.Google Scholar
  284. 284.
    Schwartz, M. M. and Lewis, E. J., 1985, Focal segmental glomerular sclerosis: The cellular lesion, Kidney Int. 24: 968–974.Google Scholar
  285. 285.
    Ito, H., Yoshikawa, N., Aozai, F., Hazikano, H., Sakaguchi, H., Akamatsu, R., Matsuo, T., and Matsuyama, S., 1984, Twenty-seven children with focal segmental glomerulosclerosis: Correlation between the segmental location of the glomerular lesions and prognosis, Clin. Nephrol. 22: 9–14.PubMedGoogle Scholar
  286. 286.
    Zimmerman, S. W., 1984, Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation, Clin. Nephrol. 22: 32–38.PubMedGoogle Scholar
  287. 287.
    Axelsen, R. A., Seymour, A. E., Mathew, T. H., Fisher, G., Canny, A., and Pascoe, V., 1984, Recurrent focal glomerulosclerosis in renal transplants, Clin. Nephrol. 21: 110–114.PubMedGoogle Scholar
  288. 288.
    Hosenpud, J., Piering, W. F., Carancis, J. C., and Kauffman, H. M., 1985, Successful second kidney transplantation in a patient with focal glomerulosclerosis, Am. J. Nephrol. 5: 299–304.PubMedGoogle Scholar
  289. 289.
    Wingen, A-M., Muller-Wiefel, D. E., and Scharer, K., 1985, Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome, Clin. Nephrol. 23: 35–40.PubMedGoogle Scholar
  290. 290.
    Frey, F.J. and Frey, B. M., 1984, Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome, Am. J. Kidney Dis. 3: 339–348.PubMedGoogle Scholar
  291. 291.
    Imbasciati, E., Gusmano, R., Edefonti, A., Zucchelli, P., Pozzi, C., Grassi, Delia Volpe, M., Perfumo, F., Petrone, P., Picca, M., Appiani, A. C., Pasquali, S., and Ponticelli, C., 1985, Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome, Br. Med. J. 291: 1305–1308.Google Scholar
  292. 292.
    Tejani, A., Phadke, K., Nicastri, A., Adamson, O., Chen, C. K., Trachtman, H., and Tejani, C., 1985, Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions, Nephron 41: 170–173.PubMedGoogle Scholar
  293. 293.
    Srivastava, R. N., Agarwal, R. K., Choudhry, V. P., Moudgil, A., Bhuyan, U. N., and Sunderam, K. R., 1985, Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence, Int. J. Ped, Nephrol. 6: 245–250.Google Scholar
  294. 294.
    Geary, D. F., Farine, M., Thorner, P., and Baumal, R., 1984, Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: A reappraisal, Clin. Nephrol. 22: 109–113.PubMedGoogle Scholar
  295. 295.
    Feehally, J., Beattie, T. J., Brenchley, P. E. C., Coupes, B. M., Houston, I. B., Mallick, N. P., and Postlethwaite, R. J., 1984, Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy, N. Engl. J. Med. 310: 415–420.PubMedGoogle Scholar
  296. 296.
    Steinberg, A. D., 1984, Cyclophosphamide: Should it be used daily, monthly or never? N. Engl. J. Med. 310: 458–460.PubMedGoogle Scholar
  297. 297.
    Broyer, M., Meziane, A., Kleinknecht, C., and Niaudet, P., 1985, Nitrogen mustard therapy in idiopathic nephrotic syndrome of childhood, Int. J. Pediatr. Nephrol. 6: 29–34.PubMedGoogle Scholar
  298. 298.
    Torres, V. E., Velosa, J. A., Holley, K. E., and Frohnert, P. P., 1984, Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation, Mayo Clin. Proc. 59: 146–152.PubMedGoogle Scholar
  299. 299.
    Velosa, J. A., Torres, V. E., Donadio, J. V., Wagoner, R. D., Holley, K. E., and Offord, K. P., 1985, Treatment of severe nephrotic syndrome with meclofenamate: An uncontrolled pilot study, Mayo Clin. Proc. 60: 586–592.PubMedGoogle Scholar
  300. 300.
    Michielsen P. and Varenterghem, Y., 1983, Proteinuria and nonsteroidal anti-inflammatory drugs, Adv. Nephrol. 12: 139–150.Google Scholar
  301. 301.
    Zimmerman, S. W., 1985, Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis, Nephron 40: 241–245.PubMedGoogle Scholar
  302. 302.
    Abrass, C. K., Davidson, W. D., Guziel, L., and Grinnell, V., 1984, Therapeutic percutaneous renal artery occlusion with a detachable balloon, Am. J. Nephrol. 4: 317–321.PubMedGoogle Scholar
  303. 303.
    Francis, K. L., Jenis, E. H., Jensen, G. E., and Calcagno, P. L., 1984, Goldassociated nephropathy, Arch, Pathol. Lab. Med. 108: 234–238.Google Scholar
  304. 304.
    Textor, S. C., Gephardt, G. N., Bravo, E. L., Tarzai, R. C., Fouad, F. M., Tubbs, and R., McMahon, J. T., 1982, Membranous glomerulopathy associated with captopril therapy, Am. J. Med. 74: 705–712.Google Scholar
  305. 305.
    Delfraissy, J. F., Galanaud, P., Balavoine, J. F., Wallon, C., and Dormont, J., 1984, Captopril and immune regulation, Kidney Int. 25: 925–929.PubMedGoogle Scholar
  306. 306.
    Donker, A. B. J., Venuto, R. C., Uladutiu, A. O., Brentjens, J. R., and Andres, G. A., 1984, Effects of prolonged administration of D-penicillamine or captopril in various strains of rats, Clin. Immunol. Immunopathol. 30: 142–155.PubMedGoogle Scholar
  307. 307.
    Berthoux, F. C., Laurent, B., Le Petit, J. C., Genin, C., Broutin, F., Touraine, F., Hassan, A. A., and Champailler, A., 1984, Immunogenetics and immunopathology of human primary membranous glomerulonephritis: HLA-A, B, DR antigens; functional activity of splenic macrophage Fc-receptors and peripheral blood T-lymphocyte subpopulations, Clin. Nephrol. 22: 15–20.PubMedGoogle Scholar
  308. 308.
    Hiki, Y., Kobayashi, Y., Itoh, I., and Kashiwagi, N., 1984, Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan, Kidney Int. 25: 953–967.PubMedGoogle Scholar
  309. 309.
    Tomura, S., Kashiwabara, H., Tuchida, H., Shishido, H., Sakurai, S., Miyajima, T., Tsuji, K., and Takeuchi, J., 1984, Strong association of idiopathic membranous nephropathy with HLA-DR2 and MT1 in Japanese, Nephron 36: 242–245.PubMedGoogle Scholar
  310. 310.
    Gran, J. T., Husby, G., and Thorsby, E., 1983, HLA DR antigens and gold toxicity, Ann. Rheum. Dis. 42: 63–66.PubMedGoogle Scholar
  311. 311.
    Short, C. D., Feehally, J., Gokal, R., and Mallick, N. P., 1984, Familial membranous nephropathy, Br. Med. J. 289: 1500.Google Scholar
  312. 312.
    Bansal, V. K., Kozeny, G. A., Fresco, R., Vertuno, L. L., and Hano, J. E., 1985, De novo membranous nephropathy following renal transplantation between conjoint twins, Transplantation 41: 404–406.Google Scholar
  313. 313.
    First, M. R., Mendoza, N., Maryniak, R. K., and Weiss, M. A., 1984, Membranous glomerulopathy following kidney transplantation, Transplantation 38: 603–607.PubMedGoogle Scholar
  314. 314.
    Pettersson, E., Tornroth, T., and Miettinen, 1984, Simultaneous antiglomerular basement membrane and membranous glomerulonephritis: Case report and literature review, Clin. Immunol. Immunopathol. 31: 171–180.PubMedGoogle Scholar
  315. 315.
    Stuart, K., Fallon, B. G., and Cardi, M. A., 1984, Development of the nephrotic syndrome in a patient with prostatic carcinoma, Am. J. Med. 80: 295–298.Google Scholar
  316. 316.
    Iida, H., Mizumura, Y., Uraoka, T., Takata, M., Sugimoto, T., Miwa, A., and Yamagishi, T., 1985, Membranous glomerulonephritis associated with enterococcal endocarditis, Nephron 40: 88–90.PubMedGoogle Scholar
  317. 317.
    Sasaki, J., Hara, F., Motooka, T., Naito, S., and Arakawa, K., 1985, Nephrotic syndrome associated with hyper-high-density lipoproteinemia potentiated by prednisolone therapy, Nephron 41: 110–113.PubMedGoogle Scholar
  318. 318.
    Yoshikawa, N., Ito, H., Yamada, Y., Hashimoto, H., Katayama, Y., Matsuyama, S., Hasegawa, O., Okada, S., Hajikano, H., Yoshizawa, H., Mayumi, M., and Matsuo, T., 1985, Membranous glomerulonephritis associated with hepatitis B antigen in children: A comparison with idiopathic membranous glomerulonephritis, Clin. Nephrol. 23: 28–34.PubMedGoogle Scholar
  319. 319.
    Bonsib, S. M., 1985, Scanning electron microscopy of acellular glomeruli in nephrotic syndrome, Kidney Int. 27: 678–684.PubMedGoogle Scholar
  320. 320.
    Weidner, N. and Lorentz, W. B., 1986, Scanning electron microscopy of the acellular glomerular basement membranes in idiopathic membranous glomerulopathy, Lab. Invest. 54: 84–92.PubMedGoogle Scholar
  321. 321.
    Honkanen, E., 1986, Survival in idiopathic membranous glomerulonephritis, Clin. Nephrol. 25: 122–128.PubMedGoogle Scholar
  322. 322.
    Kida, H., Asamoto, T., Yokoyama, H., Tomosugi, N., and Hattori, N., 1986, Long-term prognosis of membranous nephropathy, Clin. Nephrol. 25: 64–69.PubMedGoogle Scholar
  323. 323.
    Davison, A. M., Cameron, J. S., Kerr, D. N. S., Ogg, C. S., and Wilkinson, R. W., 1984, The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults, Clin. Nephrol. 22: 61–67.PubMedGoogle Scholar
  324. 324.
    Tu, W. H., Petitti, D. B., Biava, C. G., Tulunary, O., and Hopper, J., 1984, Membranous nephropathy: Predictors of terminal renal failure, Nephron 36: 118–124.PubMedGoogle Scholar
  325. 325.
    Ponticelli, C., Zucchelli, P., Imbasciati, E., Cagnoli, L., Pozzi, C., Passerini, P., Grassi, C., Limido, D., Pasquali, S., Volpinin T., Sasdelli, M., and Locatelli, F., 1984, Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy, N. Engl. J. Med. 310: 946–950.PubMedGoogle Scholar
  326. 326.
    Cattran, D., Cardella, C., Charron, R., Roscoe, J., Cole, E., Bear, R., and Corey, P., 1985, Results of a controlled trial of alternate day prednisone (ADS) in idiopathic membranous glomerulonephritis (IMGN), Kidney Int. 27:600 (Abstr.).Google Scholar
  327. 327.
    Zamurovic, D. and Churg, J., 1984, Idiopathic and secondary mesangiocapillary glomerulonephritis, Nephron 38: 145–153.PubMedGoogle Scholar
  328. 328.
    Cameron, J. S., Turner, D. R., Heaton, J., Williams, D. G., Ogg, C. S., Chantler, C., Haycock, G. B., and Kicks, J., 1982, Idiopathic mesangiocapillary glomerulonephritis, Am. J. Med. 74: 175–192.Google Scholar
  329. 329.
    Watson, A. R., Poucell, S., Thorner, P., Arbus, G. S., Ranee, C. P., and Baumal, R., 1984, Membranoproliferative glomerulonephritis type I in children: Correlation of clinical features with pathologic subtypes, Am. J. Kidney Dis. 4: 141–146.PubMedGoogle Scholar
  330. 330.
    The Southwest Pediatric Nephrology Study Group, 1985, Dense deposit disease in children: Prognostic value of clinical and pathologic indicators, Am. J. Kidney Dis. 6: 161–169.Google Scholar
  331. 331.
    Strife, C. F., Jackson, E. C., and McAdams, A. J., 1984, Type III membranoproliferative glomerulonephritis: Long-term clinical and morphologic evaluation, Clin. Nephrol. 21: 323–334.PubMedGoogle Scholar
  332. 332.
    McEnery, P. T., McAdams, A. J., and West, C. D., 1985, The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis, Medicine 64: 401–423.PubMedGoogle Scholar
  333. 333.
    Warady, B. A., Guggenheim, S. J., Sedman, A., and Lum, G. M., 1985, Prednisone therapy of membranoproliferative glomerulonephritis in children, J. Pediatr. 107: 702–707.PubMedGoogle Scholar
  334. 334.
    Mota-Hernandez, F., Gordillo-Paniagua, G., Munoz-Arizpe, R., Lopez-Arriaga, J. A., and Barboza-Madueno, L., 1985, Prednisone versus placebo in membranoproliferative glomerulonephritis: Long-term clinicopathological correlations, Int. J. Pediatr. Nephrol. 6: 25–28.PubMedGoogle Scholar
  335. 335.
    Donadio, J. V., Anderson, C. F., Mitchell, J. C., Ill, Holley, K. E., Ilstrup, D. M., Fuster, V., and Chesebro, J. H., 1984, Membranoproliferative glomerulonephritis: A prospective clinical trial of platelet-inhibitor therapy, N. Engl. J. Med. 310: 1421 - 1426.Google Scholar
  336. 336.
    Cattran, D. C., Cardella, C. J., Roscoe, J. M., Charron, R. C., Ranee, P. C., Ritchie, S. M., and Corey, P. N., 1985, Results of a controlled drug trial in membranoproliferative glomerulonephritis, Kidney Int. 27: 436–441.PubMedGoogle Scholar
  337. 337.
    Zimmerman, S. W., Moorthy, A. V., Dreher, W. H., Friedman, A., and Varanasi, U., 1983, Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis, Am. J. Med. 75: 920–927.PubMedGoogle Scholar
  338. 338.
    Donadio, J. V., 1984, Treatment of glomerular disease with anticoagulant, antiplatelet and nonsteroidal anti-inflammatory agents, Symposium on Treatment of Glomerulonephritis, in: Nephrology, Volume 1, Proceedings of the IX International Congress of Nephrology ( R. R. Robinson, ed.), Spinger Verlag, New York, pp. 1486 - 1497.Google Scholar
  339. 339.
    McGinley, E., Watkins, R., and McLay, A., and Boulton-Jones, J. M., 1985, Plasma exchange in the treatment of mesangiocapillary glomerulonephritis, Nephron 40: 385 - 390.PubMedGoogle Scholar
  340. 340.
    Serra, A., Cameron, J. S., Turner, D. R., Hartley, B., Ogg, C. S., Neild, G. H., Williams, D. G., Taube, D., Brown, C. B., and Hicks, J. A., 1984, Vasculitis affecting the kidney: Presentation, histopathology and long-term outcome, Q.J. Med. 210: 181–207.Google Scholar
  341. 341.
    Dienstag, J. L., 1985, Case Records of the Massachusetts General Hospital (Case 36-1985), N. Engl. J. Med. 313: 622–631.Google Scholar
  342. 342.
    D’Agati, V., Chander, P., Nash, M., and Mancilla-Jimenez, P., 1986, Idiopathic microscopic polyarteritis nodosa: Ultrastructural observations on the renal vascular and glomerular lesions, Am. J. Kidney Dis. 7: 95–110.PubMedGoogle Scholar
  343. 343.
    Moyer, C. F. and Reinisch, C. L., 1984, The role of vascular smooth muscle cells in experimental autoimmune vasculitis: I. The initiation of delayed type hypersensitivity angiitis, Am. J. Pathol. 117: 380–390.PubMedGoogle Scholar
  344. 344.
    Hart, M. N., Tassell, S. K., Sadewasser, K. L., Schelper, R. L., and Moore, S. A., 1985, Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle, Am. J. Pathol. 119: 448–455.PubMedGoogle Scholar
  345. 345.
    Editorial, 1985, Systemic vasculitis, Lancet 1: 1352–1253.Google Scholar
  346. 346.
    Balow, J. E. and Austin, H. A., 1984, Vasculitic diseases of the kidney, in: Therapy of Renal Diseases and Related Disorders (W. N. Suki and S. G. Massry, eds), Martinus Nijhoff, Boston, pp. 273–282.Google Scholar
  347. 347.
    Levine, B. W., 1985, Case Records of the Massachusetts General Hospital (Case 16-1985), N. Engl. J. Med. 312: 1042–1052.Google Scholar
  348. 348.
    Parfrey, P. S., Hutchinson, T. A., Jothy, S., Cramer, B. C., Martin, J., Hanley, J. A., and Seeley, J. F., 1985, The spectrum of diseases associated with necrotizing glomerulonephritis and its prognosis, Am. J. Kidney Dis. 6: 387–396.PubMedGoogle Scholar
  349. 349.
    Weiss, M. A. and Crissman, J. D., 1985, Segmental necrotizing glomerulonephritis: Diagnostic, prognostic and therapeutic significance, Am. J. Kidney Dis. 6: 199–211.PubMedGoogle Scholar
  350. 350.
    Serra, A. and Cameron, J. S., 1985, Clinical and pathologic aspects of renal vasculitis, Semin. Nephrol. 5: 15–33.PubMedGoogle Scholar
  351. 351.
    Mark, E. J. and Ramirez, J. F., 1985, Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis, Arch. Pathol. Lab. Med. 109: 413–418.PubMedGoogle Scholar
  352. 352.
    Steinberg, A. D., Raveche, E. S., Laskin, C. A., Smith, H. K., Santoro, T., and Miller, M. L., 1984, Systemic lupus erythematosus: Insights from animal models, Ann. Intern. Med. 100: 714–727.PubMedGoogle Scholar
  353. 353.
    Schwartz, R. S. and Stollar, B. D., 1985, Origins of anti-DNA autoantibodies, J. Clin. Invest. 75: 321–327.PubMedGoogle Scholar
  354. 354.
    Madaio, M. P., 1984, Deciphering the pathogenesis of systemic lupus erythematosus: The use of monoclonal autoantibodies as probes, Plasma Ther. Transfus. Technol. 5: 481–495.Google Scholar
  355. 355.
    Halpern, R., Davidson, A., Lazo, A., Solomon, G., Lahita, R., and Diamond, B., 1985, Familial systemic lupus erythematosus, J. Clin. Invest. 76: 731–736.PubMedGoogle Scholar
  356. 356.
    Andre-Schwartz, J., Datta, S. K., Shoenfeld, Y., Isenberg, D. A., Stollar, B. D., and Schwartz, R. S., 1984, Binding of cytoskeletal proteins by monoclonal anti-DNA lupus autoantibodies, Clin. Immunol. Immunopathol. 31: 261–271.PubMedGoogle Scholar
  357. 357.
    Isenberg, D. A., Shoenfeld, Y., Madaio, M. P., Rauch, J., Reichlin, M., Stollar, B. D., and Schwartz, R. S., 1984, Anti-DNA antibody idiotypes in systemic lupus erythematosus, Lancet 2: 418–421.Google Scholar
  358. 358.
    Cairns, E., Block, J., and Bell, D. A., 1984, Anti-DNA autoantibody-producing hybridomas of normal human lymphoid cell origin, J. Clin. Invest. 74: 880–887.PubMedGoogle Scholar
  359. 359.
    Izui, S., Kelley, V. E., Masuda, K., Yoshida, H., Roths, J. B., and Murphy, E. D., 1984, Induction of various autoantibodies by mutant gene lpr in several strains of mice, J. Immunol. 133: 227–233.PubMedGoogle Scholar
  360. 360.
    Balow, J. E. and Tsokos, G. C., 1984, T and B lumphocyte function in patients with lupus nephritis: Correlation with renal pathology, Clin. Nephrol. 21: 93–97.PubMedGoogle Scholar
  361. 361.
    Naparstek, Y., Schattner, A., Duggan, D., Madaio, M., Schwartz, R., Stollar, B. D., Kabat, E., Frangione, B., Goni, F., and Atkinson, P., 1984, Structural and immunochemical resemblances between monoclonal anti-DNA autoantibodies and monoclonal anti-bacterial antibodies, Clin. Res. 32: 507A (Abstr.).Google Scholar
  362. 362.
    Isenberg, D. A. and Collins, C., 1985, Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients, J. Clin. Invest. 76: 287–294.PubMedGoogle Scholar
  363. 363.
    Stohl, W., Crow, M. K., and Kunkel, H. G., 1985, Systemic lupus erythematosus with deficiency on the T4 epitope on T helper/induced cells, N. Engl. J. Med. 312: 1671–1678.PubMedGoogle Scholar
  364. 364.
    Halpern, R., Schiffenbauer, J., Solomon, G., and Diamond, B., 1984, Detection of masked anti-DNA antibodies in lupus sera by a monoclonal antiidiotype, J. Immunol. 133: 1852–1856.PubMedGoogle Scholar
  365. 365.
    Tsokos, G. C., Gorden, P., Antonovych, T., Wilson, C. B., and Balow, J. E., 1985, Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors, Ann. Intern. Med. 102: 176–181.PubMedGoogle Scholar
  366. 366.
    Couser, W. G., Rennke, H., Bhan, A., Cummings, N. B., Garovoy, M., and Scherbenske, M. J., 1985, Summary report: National Institutes of Health Conference on monoclonal antibodies in renal research, Am. J. Kidney Dis. 6: 7–17.PubMedGoogle Scholar
  367. 367.
    McCoubrey-Hoyer, A., Okarma, T. B., and Holman, H. R., 1984, Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus, Am. J. Med. 77: 23 - 34.PubMedGoogle Scholar
  368. 368.
    Emlen, W., Ansari, R., and Burdick, G., 1984, DNA-anti-DNA immune complexes. Antibody protection of a discrete DNA fragment from DNase digestion in vitro, J. Clin. Invest. 74: 185–190.PubMedGoogle Scholar
  369. 369.
    Sekita, K., Doi, T., Erimuso, Yoshido, H., Kanatsu, K., and Hamashima, Y., 1984, Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus, Clin. Exp. Immunol 55: 487–494.Google Scholar
  370. 370.
    Adu, D. and Williams, D. G., 1984, Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus, Clin. Exp. Immunol 55: 495–501.PubMedGoogle Scholar
  371. 371.
    Valentijn, R. M., van Overhagen, H., Hazevoet, H. M., Hermans, J., Cats, H. A., Daha, M. R., and van Es, L. A., 1985, The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus, Arth. Rheum. 28: 904–913.Google Scholar
  372. 372.
    Valentijin, R. M., van Overhagen, H., Hazevoet, H. M., Hermans, J., Cats, A., Daha, M. R., and van Es, L. A., 1985, The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus, Arth. Rheum. 28: 904–913.Google Scholar
  373. 373.
    van der Woude, F. J., van der Giessen, M., Kallenberg, C. G. M., and Ouwehand, W., Beekhuis, H., Beelen, J. M., van Son, W. J., Hoedemaeker, J., and van der Hem, G. K., 1984, Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity? Clin. Exp. Immunol. 55: 473–480.PubMedGoogle Scholar
  374. 374.
    van der Woude, F. J., Kallenberg, C. G. M., Limburg, P. C., Beekhuis, H., Ouwehand, W., van der Giessen, M., Hoedemaeker, J., and van der Hem, G. K., 1984, Reticuloendothelial Fc receptor function in SLE patients. II. Associations with humoral immune response parameters in vivo and in vitro, Clin. Exp. Immunol. 55: 481–486.Google Scholar
  375. 375.
    Waldo, F. B., Forristal, J., Beischel, L., and West, C. D., 1985, A circulating inhibitor of fluid-phase amplification, C3 convertase formation in systemic lupus erythematosus, J. Clin. Invest. 75: 1786–1795.PubMedGoogle Scholar
  376. 376.
    Daha, M. R., Hazevoet, H. M., and van Es, L. A., 1984, Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus, Clin. Exp. Immunol. 56: 614–620.PubMedGoogle Scholar
  377. 377.
    Gabrielli, A., Corvetta, A., Montroni, M., Rupoli, S., and Danieli, G., 1985, Immune deposits in normal skin or patients with systemic lupus erythematosus: Relationship to the serum capacity to solubilize immune complexes, Clin. Immunol. Immunopathol. 36: 266–274.PubMedGoogle Scholar
  378. 378.
    Schwartz, M. M., 1985, The role of renal biopsy in the management of lupus nephritis, Semin. Nephrol. 5: 255–263.PubMedGoogle Scholar
  379. 379.
    Austin, H. A., Ill, Muenz, L. R., Joyce, K. M., Antonovych, T. T., and Balow, J. E., 1984, Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome, Kidney Int. 25: 689–695.Google Scholar
  380. 380.
    Banfi, G., Mazzaucco, G., Di Belgiojoso, G. B., Bosisio, M. B., Stratta, P., Confalonieri, R., Ferrario, F., Imbasciati, E., and Monga, G., 1985, Morphological parameters in lupus nephritis: Their relevance for classification and relationship with clinical and histological findings and outcome, Q. J. Med. 55: 153–168.PubMedGoogle Scholar
  381. 381.
    Magil, A. B., Ballon, H. S., Chan, V., Lirenman, D. S., Rae, A., and Sutton, R. A. L., 1984, Diffuse proliferative lupus glomerulonephritis: Determination of prognostic significance of clinical, laboratory and pathologic factors, Medicine 63: 210–220.PubMedGoogle Scholar
  382. 382.
    Lee, H. S., Mujais, S. K., Kasinath, B. S., Spargo, B. H., and Katz, A. I., 1984, Course of renal pathology in patients with systemic lupus erythematosus, Am. J. Med. 77: 612–620.PubMedGoogle Scholar
  383. 383.
    Hochberg, M. C., Boyd, R. E., Ahearn, J. M., Arnett, F. C., Bias, W. B., Provost, T. T., and Stevens, M. B., 1985, Systemic lupus erythematosus: A review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets, Medicine 64: 285–295.PubMedGoogle Scholar
  384. 384.
    Dumas, R., 1985, Lupus nephritis: Collaborative study by the French Society of Paediatric Nephrology, Arch. Dis. Child. 60: 126–128.PubMedGoogle Scholar
  385. 385.
    Rubin, L. A., Urowitz, M. B., and Gladman, D. D., 1985, Mortality in systemic lupus erythematosus: The bimodal pattern revisited, Q. J. Med. 55: 87–98.Google Scholar
  386. 386.
    Lee, H. S. and Spargo, B. H., 1985, A renal biopsy study of lupus nephropathy in the United States and Korea, Am. J. Kidney Dis. 5: 242–250.PubMedGoogle Scholar
  387. 387.
    Kallenberg, C. G. M., Schweitzer, C., Jong, P. E., Donker, A. J. M., and van der Hem, G. K., 1984, Decreased filtration fraction during active proliferative lupus nephritis: Relation to disease activity and reversibility of renal function, Clin. Nephrol. 22: 223–229.PubMedGoogle Scholar
  388. 388.
    Bakir, A. A., Lopez-Majano, V., Hryhorczuk, D. O., Rhee, H. L., and Dunea, G., 1984, Appraisal of lupus nephritis by renal imaging with gallium-67, Am. J. Med. 79: 175–182.Google Scholar
  389. 389.
    Friedman, S., Strober, S., Field, E. H., Silverman, E., and Myers, B. D., 1984, Glomerular capillary wall function in human lupus nephritis, Am. J. Physiol. 246: F580–F591.PubMedGoogle Scholar
  390. 390.
    Caruana, R. J., Barish, C. F., and Buckalew, V. M., 1985, Complete distal renal tubular acidosis in systemic lupus: Clinical and laboratory findings, Am. J. Kidney Dis. 6: 59–63.PubMedGoogle Scholar
  391. 391.
    Yeung, C. K., Wong, K. L., Ng, R. P., and Ng, W. L., 1984, Tubular dysfunction in systemic lupus erythematosus, Nephron 36: 84–88.PubMedGoogle Scholar
  392. 392.
    Wang, F. and Looi, L. M., 1984, Systemic lupus erythematosus with membranous lupus nephropathy in Malaysian patients, Q. J. Med. 210: 209–226.Google Scholar
  393. 393.
    Alpers, C. E., Hopper, J., Bernstein, M. J., and Biava, C. G., 1984, Late development of systemic lupus erythematosus in patients with glomerular “fingerprint” deposits, Ann. Intern. Med. 100: 66–68.PubMedGoogle Scholar
  394. 394.
    Williams, W. W., Shah, D. J., Morgan, A. G., and Alleyne, G. A. O., 1985, Membranous glomerulonephropathy with crescents in systemic lupus erythematosus, Am. J. Nephrol. 5: 158–162.PubMedGoogle Scholar
  395. 395.
    West, S. G., McMahon, M., and Portanova, J. P., 1984, Quinidine-induced lupus erythematosus, Ann. Intern. Med. 100: 840–842.PubMedGoogle Scholar
  396. 396.
    Ihle, B. U., Whitworth, J. A., Dowling, J. P., and Kincaid-Smith, P., 1984, Hydralazine and lupus nephritis, Clin. Nephrol. 22: 230–238.PubMedGoogle Scholar
  397. 397.
    Cush, J. J. and Goldings, 1985, Drug-induced lupus: Clinical spectrum and pathgenesis, Am. J. Med. Sci. 290: 36–45.PubMedGoogle Scholar
  398. 398.
    Correia, P., Cameron, J. S., Ogg, C. S., Williams, D. G., Bewick, M., and Hicks, J. A., 1984, End-stage renal failure in systemic lupus erythematosus with nephritis, Clin. Nephrol. 22: 293–302.PubMedGoogle Scholar
  399. 399.
    Coggins, C. H., 1984, Treatment of lupus nephritis, Nephrol. Lett. 1: 1–4.Google Scholar
  400. 400.
    Donadio, J. V., 1984, Cytotoxic-drug treatment of lupus nephritis, N. Engl. J. Med. 311: 528–529.PubMedGoogle Scholar
  401. 401.
    Carette, S., Klippel, J. H., Decker, J. L., Austin, H. A., Plotz, P. H., Steinberg, A. D., and Balow, J. E., 1983, Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up, Ann. Intern. Med. 99: 1–7.PubMedGoogle Scholar
  402. 402.
    Kelson, D. T. and Anderson, J., 1984, Evidence for the superiority of immuno-suppressive drugs and prednisone over prednisone alone in lupus nephritis, N. Engl, J. Med. 311: 1528–1533.Google Scholar
  403. 403.
    Balow, J. E., Austin, H. A., I l l, Muenz, L. R., Joyce, K. M., Antonovych, T. T., Klippel, J. H., Steinberg, A. D., Plotz, P. H., and Decker, J. L., 1984, Effect of treatment on the evolution of renal abnormalities in lupus nephritis, N. Engl. J. Med. 311: 491–495.Google Scholar
  404. 404.
    Austin, H. A., III., Klippel, J. H., Balow, J. E., Le Riche, N. G. H., Steinberg, A. D., Plotz, P. H., and Decker, J. L., 1986, Therapy of lupus nephritis: Controlled trial of prednisone and cytotoxic drugs, N. Engl. J. Med. 314: 614–619.Google Scholar
  405. 405.
    Balow, J. E. and Austin, H. A., 1983, Lupus nephritis, in: Current Therapy in Allergy and Immunology ( L. M. Lichtenstein and A. S. Fauci, ed.), B. C. Decker, Philadelphia, pp. 186–191.Google Scholar
  406. 406.
    Yeung, C. K., Wong, K. L., Wong, W. S., Ng, M. 1\, Chan, K. W., and Ng, W. L., 1984, Crescentic lupus glomerulonephritis, Clin. Nephrol. 21: 251–258.Google Scholar
  407. 407.
    Strober, S., Field, E., lloppe, R. T., Kotzin, B. L., Shemesh, O., Engleman, E., Ross, J. C., and Myers, B. D., 1985, Treatment of intractable lupus nephritis with total lymphoid irradiation, Ann. Intern. Med. 102: 450–458.PubMedGoogle Scholar
  408. 408.
    Kant, K. S., Pollak, V. E., Dosekun, A., Glas-Greenwalt, P., Weiss, M. A., and Glueck, H. I., 1985, Lupus nephritis with thrombosis and abnormal fibrinolysis: Effect of ancrod, J. Lab. Clin. Med, 105: 77–88.PubMedGoogle Scholar
  409. 409.
    Hahn, B. H. and Ebling, F. \1., 1984, Suppression of murine lupus nephritis by administration of an anti-idiotypic anti-DNA, J. Immunol. 132: 187–190.Google Scholar
  410. 410.
    Roth, D. A., Wilz, D. R., and Theil, G. B., 1985, Schonlein-Henoch syndrome in adults, Q J. Med, 55: 145–152.PubMedGoogle Scholar
  411. 411.
    Feinstein, E. L, Nord, E. P., Bacallao, R. L., Nord, E. P., and Cohen, A. H., 1985, Hematuria, proteinuria, and hypertension in a patient with multiple organ system disease, Am, J. Nephrol. 5: 217 - 224.Google Scholar
  412. 412.
    Scully, R. E., Mark, E. J., and McNeely, B. U., 1984, Case Records of the Massachusetts General Hospital, Case 40-1984, N. Engl. J. Med, 311: 904–911.Google Scholar
  413. 413.
    Raju, S. F., Chapman, S. W., Dreiling, B., and Tavassoli, M., 1984, Hairycell leukemia with the appearance of mixed cryoglobulinemia and vasculit is, Arch. Intern. Med. 144: 1300–1302.PubMedGoogle Scholar
  414. 414.
    Delaney, V. B., Fraley, D. S., Segal, D. P., and Bruns, F. J., 1984, Plasmapheresis as sole therapy in a patient, with essential mixed cryoglobulinemia, Am. J. Kidney Dis. 4: 75–79.PubMedGoogle Scholar
  415. 415.
    Evans, T. W., Nicholls, A. J., Shortland, J. R., Ward, A. M., and Brown, C. B., 1984, Acute renal failure in essential mixed cryoglobulinemia: Precipitation and reversal by plasma exchange, Clin. Nephrol. 21: 287–293.PubMedGoogle Scholar
  416. 416.
    Fauci, A. S., Haynes, B. F., Katz, P., and Wolff, S. M., 1983, Wegener’s granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years, Ann. Intern. Med. 98: 76–85.PubMedGoogle Scholar
  417. 417.
    Littlejohn, G. O., Ryan, P. J., and Holdsworth, S. R., 1985, Wegener’s granulomatosis: Clinical features and outcome in seventeen patients, Aust. NZ J. Med. 15: 241–245.Google Scholar
  418. 418.
    ten Berge, I. J. M., Wilmink, J. M., Meyer, C. J. L. M., Surachno, J., ten Veen, Ko.H., Balk, T. G., and Schellekens, P. Th.A., 1985, Clinical and immunological follow-up of patients with severe renal disease in Wegener’s granulomatosis, Am. J. Nephrol. 5: 21–29.Google Scholar
  419. 419.
    Weiss, M. A. and Crissman, J. D., 1983, Renal biopsy findings in Wegener’s granulomatosis: Segmental necrotizing glomerulonephritis with glomerular thrombosis, Hum. Pathol. 15: 943–956.Google Scholar
  420. 420.
    Glassock, R. J., Feinstein, E. I., Kitt, D., Collins, J. F., Boylen, T., and Koss, M., 985, Hemoptysis and acute renal failure in young man, Am. J. Nephrol. 5: 64–70.Google Scholar
  421. 421.
    Haworth, S. J., Savage, C. O. S., Carr, D., Hughes, J. M. B., and Rees, A. J., 1985, Pulmonary haemmorhage complicating Wegener’s granulomatosis and microscopic polyarteritis, Br. Med. J. 290: 1775–1778.Google Scholar
  422. 422.
    DeRemee, R. A., McDonald, T. J., and Weiland, L. H., 1985, Wegener’s granulomatosis: Observations on treatment with antimicrobial agents, Mayo Clin. Proc. 60: 27 - 32.PubMedGoogle Scholar
  423. 423.
    Dahlberg, P. J., Newcomer, Yutuc, W. R., and Kalfayan, B., 1984, Renal failure in Wegener’s glomulomatosis: Recovery following dialysis and cyclophosphamide prednosine therapy, Am. J. Med. Sci. 278: 47–50.Google Scholar
  424. 424.
    Hind, C. R. K., Winearls, C. G., Lockwood, C. M., Rees, A. J., and Pepys, M. B., 1984, Objective monitoring of activity in Wegener’s granulomatosis by measurement of serum C-reactive protein concentration, Clin. Nephrol. 21: 341–345.PubMedGoogle Scholar
  425. 425.
    Honkanen, E., Tornroth, T., Pettersson, E., and Kuhlback, B., 1984, Glomerulonephritis in renal allografts: Results of 18 years of transplantations, Clin. Nephrol. 21: 210–219.PubMedGoogle Scholar
  426. 426.
    Cats, S., Galton, J., and Terasaki, P. I., 1985, Effect of recipient’s original disease on the outcome of renal transplantation, Transplantation 17: 2811–2814.Google Scholar
  427. 427.
    Boyce, N., Holdsworth, S., Atkins, R., and Dowling, J., 1985, De-novo antiGBM-antibody-induced glomerulonephritis in a renal transplant, Clin. Nephrol. 23: 148 - 151.Google Scholar
  428. 428.
    Maryniak, R. K., First, M. R., and Weiss, M. A., 1985, Transplant glomerulopathy: Evolution of morphologically distinct changes, Kidney Int. 27: 799–806.PubMedGoogle Scholar
  429. 429.
    First, M. R., Vaidya, P. N., Maryniak, R. K., Weiss, M. A., Munda, R., Fidler, J. P., Penn, I., and Alexander, J. W., 1984, Proteinuria following transplantation, Transplantation 38: 607 - 612.PubMedGoogle Scholar
  430. 430.
    Drummond, K. N., 1985, Editorial Retrospective. Hemolytic uremic syndrome—Then and now, N. Engl. J. Med. 312: 116–118.PubMedGoogle Scholar
  431. 431.
    Remuzzi, G. and Rossi, E. C., 1985, The hemolytic uremic syndrome, Int., J. Artif. Organs 8: 171–174.Google Scholar
  432. 432.
    Feldhoff, C., Pistor, K., Bachmann, H., Horacek, U., and Olbing, H., 1984, Hemolytic uremic syndrome in 3 siblings, Clin. Nephrol. 22: 44–46.PubMedGoogle Scholar
  433. 433.
    Wyatt, R. J., Jones, D., Stapleton, F. B., Roy, S., Ill, Odom, T. W., and McLean, R. H., 1985, Recurrent hemolytic-uremic syndrome with the hypomorphic fast allele of the third component of complement, J. Pediatr. 107: 564–565.Google Scholar
  434. 434.
    Merrill, R. H., Knupp, C. L., and Jennette, J. C., 1985, Familial thrombodc microangiopathy, Q.J. Med. 57: 749–759.PubMedGoogle Scholar
  435. 435.
    Gelfand, J., Truong, L., Stern, L., Pirani, C. L., and Appel, G. B., 1985, Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: Treatment with plasma infusion, Am. J. Kidney Dis. 6: 154–160.PubMedGoogle Scholar
  436. 436.
    Ortega Marcos, O., Escuin, F., Miguel, J. L., Gomez Fernandez, P., Perez Fontan, M., Selgas, R., and Sanchez Sicilia, G., 1985, Hemolytic uremic syndrome in a patient with gastric adenocarcinoma: Partial recovery of renal function after gastrectomy, Clin. Nephrol. 24: 265–268.PubMedGoogle Scholar
  437. 437.
    Jackson, A. M., Rose, B. D., Graff, L. G., Jacobs, J. B., Schwartz, J. H., Strauss, G. M., Yang, J. P. S., Rudnick, M. R., Elfnbein, I. B., and Nariins, R. G., 1984, Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy, Ann. Intern. Med. 101: 41–44.PubMedGoogle Scholar
  438. 438.
    Giroux, L., Bettez, P., and Giroux, L., 1985, Mitomycin-C nephrotoxicity: A clinico-pathologic study of 17 cases, Am. J. Kidney Dis. 6: 28–39.PubMedGoogle Scholar
  439. 439.
    Proia, A. D., Harden, E. A., and Silberman, H. R., 1984, Mitomycin-induced hemolytic-uremic syndrome, Arch. Pathol. Lab. Med. 108: 959–962.PubMedGoogle Scholar
  440. 440.
    Van Buren, D., Van Buren, C. T., Flechner, S. M., Maddox, AmM., Verani, R., and Kahan, B. D., 1984, De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporin, Surgery 98: 54–62.Google Scholar
  441. 441.
    Kelton, J. G., Moore, J., Santos, A., and Sheridan, D., 1984, Detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura, Ann. Intern. Med. 101: 589–593.PubMedGoogle Scholar
  442. 442.
    Monnens, L., van der Meer, W., Langenhnuysen, C., van Munster, P., and van Oostrom, C., 1985, Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood, Clin. Nephrol. 24: 135–137.PubMedGoogle Scholar
  443. 443.
    Lian, E. C-Y., Mui, P. T. K., Siddiqui, F. A., Chiu, A. Y. Y., and Chiu, L. L. S., 1984, Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G., J. Clin. Invest. 73: 548–555.PubMedGoogle Scholar
  444. 444.
    Cosio, F. G., Eddy, A., Mentser, M. I., and Bergstein, J. M., 1985, Decreased plasma fibronectin levels in children with hemolytic-uremic syndrome, Am. J. Med. 78: 549–554.PubMedGoogle Scholar
  445. 445.
    Bloom, A., Hannaford, P. A., Greaves, M., Preston, F. E., and Brown, C. B., 1985, Hemolytic-uremic syndrome: Demonstration of abnormalities of platelet reactivity and insensitivity to prostaglandin I2, Clin. Nephrol. 23: 85–88.PubMedGoogle Scholar
  446. 446.
    Wu, K. K., Hall, E. R., Rossi, E. C., and Papp, A. C., 1985, Serum prostacyclin binding defects in thrombotic thrombocytopenic purpura, J. Clin. Invest. 75: 168–174.PubMedGoogle Scholar
  447. 447.
    Karmali, M. A., Petric, M., Lim, C., Fleming, P. C., Arbus, G. S., and Lior, H., 1985, The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli, J. Infect. Dis. 151: 775–782.Google Scholar
  448. 448.
    Neill, M. A., Agosti, J., and Rosen, H., 1985, Hemorrhagic colitis with escherichia coli 0157: H7 preceding adult hemolytic uremic syndrome, Arch. Intern. Med. 145: 2215–2217.PubMedGoogle Scholar
  449. 449.
    Sonsino, C. L. E., Varga Morena, A., Pillion, G., Mercier, J. C., Beaufils, F., and Mathieu, H., 1984, Hemolytic-uremic syndrome: An analysis of the natural history and prognostic features, Acta Paediatr. Scand. 73: 505–514.PubMedGoogle Scholar
  450. 450.
    Moake, J. L., Byrnes, J. J., Troll, J. H., Ruby, C. K., Hong, S. L., Weinstein, M. J., and Colannino, N. M., 1985, Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura, Blood 65: 1232–1236.PubMedGoogle Scholar
  451. 451.
    Aster, R. H., 1985, Editorial Retrospective: Plasma therapy for thrombotic thrombocytopenic purpura. Sometimes it works, but why? N. Engl. J. Med. 312: 995–987.Google Scholar
  452. 452.
    Hakim, R. M., Schulman, G., Churchill, W. H., and Lazarus, J. M., 1985, Successful management of thrombocytopenia, microangiopathic anemia, and acute renal failure by plasmapheresis, Am. J. Kidney Dis. 5: 170–176.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1987

Authors and Affiliations

  • William G. Couser
    • 1
  1. 1.Division of Nephrology, Department of MedicineUniversity of Washington School of MedicineSeattleUSA

Personalised recommendations